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ABC transporter: ATP-binding cassette transporters  
AC: alternating current 
AMPA: alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
AQUA: absolute quantitation 
ATP: Adenosine-5'-triphosphate 
CDITs; culture-derived isotope tag 
CHAPS: 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate 
CID: collision induced dissociation 
CMC: critical micelles concentration  
CNBr: cyanogen bromide  
DC: direct current 
EGF: epidermal growth factor 
ESI: electrospray ionization  
FT-ICR or FT: Fourier transform ion cyclotron resonance 
FTMS: Fourier transform ion cyclotron resonance mass spectrometer 
GABA: gamma-aminobutyric acid 
GO: gene ontology 
GPCR: G protein-coupled receptor 
G protein: guanine nucleotide-binding proteins 
GTP: Guanosine-5'-triphosphate 
HCD: high energy C-trap dissociation 
HPLC: high performance liquid chromatography 
ICAT: isotope-coded affinity tags 
ICR: ion cyclotron resonance 






KDa: kilo Dalton 
KE: kinetic energy  
LTQ: Linear trap quadrupole, refers to linear ion trap 
MALDI: matrix-assisted laser desorption/ionization 
MDR: multidrug resistance  
MMTV: Mouse Mammary Tumor Virus  
MS: mass spectrometry 
NBFs:  nucleotide-binding folds 
NMDA: N-methyl D-aspartate 
ORFs: open reading frames 
PEG:  polyethylene glycol  
PM: plasma membrane 
ppb: part per billion 
ppm: part per million 
RF: radio frequency  
rms: root mean square 
SDS: sodium dodecyl sulfate 
SILAC:  stable isotope labeling by amino acid in cell culture 
SIM: selected ion monitoring 
SLC: solute carrier 
SWIFT: stored waveform inverse Fourier transform 
TGF-beta: transforming growth factor-beta  
WGA: wheat germ agglutinin 







1.1  Histone 
Histones are the chief protein components of chromatin. Five major histone classes are 
known, H1, H2A, H2B, H3 and H4. Two copies of H2A, H2B, H3 and H4, are assembled 
into an octamer wrapped around by DNA to form a nucleosome core1. The repeating 
nucleosome cores further assemble into higher-order structures which are stabilized by 
the linker histone H1(ref 2). The nucleosome, including nucleosome core, linker DNA 
and H1, is the principal packaging element of DNA within the nucleus (Fig. 1).  
 
1.1.1 Core histones 
The nucleosome core is formed of two copies of H2A, H2B, H3 and H4 and the octamer 
structure can be divided into H3-H4 tetramer and two H2A-H2B dimers1. Each histone 
consists of a globular domain and an N-terminal tail domain. The globular domain 
interacts with other histones and DNA in the nucleosome, and the N-terminal tail is 
flexible to protrude from the lateral surface of the histone octamer3. The flexible tails 
undergo a diverse array of post-translational modifications which correlate with specific 
transcriptional states3. For example, acetylated lysines in the histone N-terminal tail can 
selectively interact with the bromodomains in different transcription factors to increase 
transcriptional activity4-6. H3S10 phosphorylation is necessary for proper chromosome 
condensation and segregation7, and H3K9 methylation interacts with the chromodomains 
in heterochoromatin protein HP1 and stabilizes higher order chromatin structure8, 9. 
Because of these correlations, a histone code hypothesis has been proposed10-13.  The 
hypothesis suggests that histone proteins and their associated covalent modifications 
would affect the accessibility of DNA within the chromatin structure, thereby playing a 
major role in the regulation of gene expression. The hypothesis is raised based on the 







Figure 1. A model of chromosome structure. The double stranded DNA is wound twice 
around core histone octamers to form 10-nm nucleosomes. With the help of linker histone 
H1, nucleosomes are arranged into 30-nm fibers. The 30-nm fibers form long DNA loops. 
The loops then form minniband units of a chromosome. The picture is modified from 
Biochemistry by Reginald H. Garrett and Charles M. Grisham, second edition. 
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analyses have revealed a large number of that lie in the structured globular histone core14-
17. Hence, a model called “regulated nucleosome mobility” was proposed18. The model 
suggests that there are two states of nucleosomes, a mobile state and a relatively 
stationary state.  The post-translational modifications on the globular histone domain may 
influence the equilibrium of the two states. 
 
1.1.2 Linker histone 
The linker histone H1 is involved in assembling the “beads on a string” structure into 
higher order chromosome structure2. Compared to core histone, the linker histone is more 
heterogeneous and the temporal and spatial expression of different H1 membranes are 
also different19. Mammalian cells contain seven major variants of histone H1: H1.0, H1.1, 
H1.2, H1.3, H1.4, H1.5 (ref 20-23), and H1X24, 25.  In most human cells, H1.2 and H1.4 are 
the predominant variants26. All H1 variants in higher eukaryotes have the same general 
structure, consisting of a flexible N-terminal tail, a central conserved globular domain, 
and a lysine rich C-terminal tail27. While the globular domain is conserved both 
orthologous and paralogous, the N-terminal and C-terminal tails is conserved orthologous 
but not paralogous, i.e. it differs between isoforms in the same species19. However, the 
tri-partite structure is not conserved in lower eukaryotes. For example, in S. cerevisiae, 
the sole linker histone Hho1p possesses two globular domains28.  
The binding of histone H1 to the nucleosome core structure is largely mediated by the 
globular and the C-terminal domains, and might be regulate in part by the N-terminal 
domain19. This binding is highly dynamic. The equilibrium constant of the interaction is 
in favor of association of linker histone to DNA, therefore, most of the chromatin is 
indeed covered by histone H1(ref 29). Both in vitro30, 31 and in vivo32 experiments show 
that the binding affinity of different H1 variants to the chromatin can be hugely different. 
Although the globular domain plays a key role in regulating the binding of H1 to native 
chromatin33, since they are highly conserved between different histone variants, it was 
demonstrated that the affinity variability of H1 variants to chromatin depends on the 






terminus32. Mutations in the S/TPXK motif or phosphorylation at these sites may disrupt 
the ability of H1 to bind to chromosomes34.  
The biological function of H1 has been studies by different approaches and was 
comprehensively reviewed by Izzo et al19 and Enigmatic et al35. Although all knockout 
experiments performed in either single cell organism or higher eukaryotes show that H1 
is not essential for survival, depletion of different H1 variants in mice do show that 
different H1 variants are essential for normal development in mammals36 and different 
H1 variants play a specific roles in the control of gene expression and chromatin 
structure37.  More interestingly, a connection between H1 depletion and core histone N-
terminal tail modification and DNA methylation has been observed38, 39. By studying H1 
function in vivo and in vitro at certain model promoters, e.g. Mouse Mammary Tumor 
Virus (MMTV) promoter40-42, specific functions of some histone variants could be 
obtained.  A summary of so far known functions of different histone variants is shown in 
Fig. 2. 
 






As for core histone, post-translational modifications on linker histone H1 have also been 
studied. The first recognized covalent modification of H1 was phosphorylation43.  By 
using traditional antibody detection methods, nine phospho-sites and one methylated site 
have been identified in around 20 years35. Applying mass spectrometry (MS)-based 
proteomics approaches greatly speeds-up the identification, especially for other types of 
modifications besides phosphorylation. However, the first published papers were still 
concentrated on phosphorylation of H1 in lower eukaryotes in different cell lines44-46.  
The first comprehensive mapping of modifications of H1 variants in different tissue types 
was published by our group47. In this paper, all previously reported phospho-sites, but 
also a host of novel sites were identified, not only for phosphorylation but also 
formylation, acetylation, methylation and ubiquitination. Many of the modification sites 
locate in the globular domain. In the paper, data also showed different lysine methylation 
patterns in cell culture and mouse tissue sample, which inspired us to study the H1 
methylation in human tissues. The already known methylation site on K26 (H1.4) 
escaped identification by MS coupled with online high performance liquid 
chromatography (HPLC). This prompted us to use a complementary method, which is 







1.2 Purification and isolation of membrane proteins 
Membranes provide a selectively permeable barrier physically separating the cell from its 
environment (plasma membrane, PM) or intracellular organelles from each other and the 
cytosol (intracellular membranes). Proteins embedded in the membranes play an 
important role in fundamental biological processes, such as cell signaling, cell-cell 
communications, cell adhesion, intracellular organelle compartmentalization, ion and 
solute transport and energy generation. It has been estimated that 20-30% of the ORFs 
(open reading frames) in the various genomes encode membrane proteins48 and around 70% 
of all druggable proteins can be classified as membrane proteins49, 50. Although MS-based 
proteomics has made rapid progress in the analysis of soluble proteins in recent years, the 
analysis of membrane proteins lags behind due to their high hydrophobicity, thereby 
causing problems with the normally used aqueous buffers. The biological importance of 
membrane proteins has induced researchers to develop new technologies for membrane 
protein purification and isolation. 
 
1.2.1 General introduction of membrane proteins 
The main components for biological membrane are phospholipids and proteins, nearly at 
a 1:1 mass ratio in most animal cell membranes. Although the basic structure and 
function of the biological membranes is provided by the amphipathic phospholipid 
bilayer, membrane proteins provide unique compartment specific functions and 
communication between separated environments. Different membrane proteins are 
associated with the membranes in different ways, as illustrated in Fig. 3. Based on the 
strength of the association with the membrane, membrane proteins can be classified into 
two groups, integral membrane proteins (1 – 6, Fig. 3) and peripheral membrane proteins 
(7 and 8, Fig. 3). Integral membrane proteins are permanently attached to the membrane, 
and they contain transmembrane segments, which span the entire membrane (1 – 3, Fig. 3) 
and integral monotopic protein which are permanently attached to the membrane from 






to the lipid bilayer or to integral proteins by a combination of hydrophobic, electrostatic 
interactions, hydrogen bonds or van der Waals interactions.  
 
Figure 3. Various ways in which membrane proteins associate with the lipid bilayer. (1) 
extend across the bilayer as a single α helix, (2) as multiple α helices, or (3) as a rolled-up 
β sheet, (4) anchored to the cytosolic surface by an amphipathic α helix, (5) attached to 
the cytosolic monolayer by a covalently attached lipid chain, (6) attached to the non-
cytosolic monolayer via an oligosaccharide linker (7, 8) attached to the membrane only 
by non-covalent interactions with other membrane proteins. From Molecular Biology of 
the Cell by Alberts et al (fifth edition). 
 
1.2.2 Functions of membrane proteins  
Membrane proteins transfer either molecules or information cross the lipid bilayer. It 
takes many different membrane proteins, coordinating in a well organized manner, to 
enable this passage to work properly. According to their function, membrane proteins can 
be grouped into different families. Receptors and membrane transport proteins, including 
ion channels, solute carriers and ATP-binding cassette transporters, are two main families 








1.2.2.1   Receptors 
Receptors on the cell surface convert an extracellular ligand-binding event into 
intracellular signals, by either structure transformation or post-translational modifications, 
to activate the target cell to respond to environmental stimulus. According to their 
transduction mechanisms, most cell surface receptor proteins belong to one of three 
classes: Ion-channel-coupled receptors, G-protein-coupled receptors and enzyme-coupled 
receptors.   
 
Ion-channel-coupled receptors  
Ion-channel-coupled receptors, also known as ligand-gated (transmitter-gated) ion 
channels or ionotropic receptors, are a group of intrinsic transmembrane ion channels that 
are opened or closed in response to binding of a chemical messenger. They are involved 
in rapid synaptic signaling between nerve cells and other electrically excitable target cells 
such as nerve and muscle cells. Typical examples contain the nicotinic acetylcholine 
receptor51, ionotropic glutamate receptors including AMPA (alpha-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid) receptor52, kainate receptor53 and NMDA (N-methyl 
D-aspartate) receptors54, and GABA (gamma-aminobutyric acid) receptors a and c55. 
Most ion-channel-coupled receptors belong to a large family of homologous, multipass 
transmembrane proteins. 
 
G-protein-coupled receptors (GPCR) 
 G-protein-coupled receptors, also known as seven transmembrane domain receptors or 
heptahelical receptors, are involved in a wide variety of physiological processes, such as 
visual, olfactory and gustatory sensation, intermediary metabolism, cell growth and 
differentiation56.  The three principle components of GPCR signaling are the heptahelical 
receptor, heterotrimeric G protein and effector protein (typically an enzyme or ion 






dissociate into a GTP-bound Gα subunit and Gβγ heterodimer, either of which can 
activate a cytosolic effector. The activation of the effector can change the concentration 
of one or more small intracellular mediators (if the effector is an enzyme), or it can 
change the ion permeability of the PM (if the effector is an ion channel) and the small 
intracellular mediators (second messengers) further transmit signals intracellularly. A 
typical example of a GPCR is the metabotropic glutamate receptors57, 58. All GPCR 
belong to a large family of homologous, multipass transmembrane proteins. 
 
Enzyme-coupled receptors 
Enzyme-coupled receptors function either directly as enzymes or associate with enzymes 
that they activate. The great majority of these enzymes are protein kinases, such as 
receptor serine/threonine kinases including transforming growth factor-beta (TGF-beta), 
receptor tyrosine kinases including epidermal growth factor (EGF) receptors and insulin 
receptors. The enzyme-coupled receptors are usually single-pass transmembrane proteins 
that have their ligand-binding site outside the cell and their catalytic or enzyme-binding 
site inside.  
 
1.2.2.2   Membrane transport proteins 
Although small nonpolar molecules, such as hormone, steroid, N2, O2, and CO2, diffuse 
rapidly across the cell membrane, cell membranes are highly impermeable to large 
molecule such as amino acids, sugars and nucleotides, and charged molecules, no matter 
how small they are. Special membrane transport proteins are responsible for transferring 
such solutes across cell membranes. The proteins may assist in the movement of 
substances by facilitated diffusion or active transport. Channel proteins and carrier 








Ion channels  
Ion channels are pore-forming proteins that help establish and control the small voltage 
gradient across the PM of all living cells. Typical assemblies of ion channel usually 
involve a circular arrangement of identical or homologous proteins closely packed around 
a water-filled pore through the lipid bilayer. The pore-forming subunit(s) are called the α 
subunit, and the auxiliary subunits are called β, γ or δ subunit. For example, the voltage-
gated sodium channel in mammalian neurons is composed of a 260 kDa α subunit which 
forms the pore and one or more auxiliary β subunits59, and the voltage-dependent calcium 
channels are formed as a complex of α1, α2δ, β1-4, and γ, where the α1 subunit has 24 
putative transmembrane segments and forms the ion conducting pore60. 
Classified by the nature of their gating, ion channels can be divided into voltage-gated 
ion channels and ligand-gated ion channels.  As the name indicates, voltage-gated ion 
channels activate or inactivate depending on the voltage gradient across the PM, whereas 
ligand-gated ion channels activate or inactivate depending on binding of ligands to the 
channel. Ligand-gated ion channels also named ion-channel-coupled receptors have 
already been discussed before. Typical voltage-gated ion channels encompass voltage-
gated potassium channels61, voltage-gated sodium channels59, voltage-gated calcium 
channels60 and voltage-gated proton channels62. 
 
Solute carriers 
Solute carriers are proteins that transport a specific substance or group of solutes through 
intracellular compartments or in extracellular fluids (e.g. in the blood) across the cell 
membrane. Unlike ion channels, which interact with the solute to be transported very 
weakly and can only allow solutes to cross the membrane passively, solute carrier 
proteins bind the specific solute to be transported and undergo a series of conformational 
changes to transfer the bound solute across the membrane. This transport can be either 
facilitated diffusion or active transport. The SoLute Carrier (SLC), for example, includes 







ATP-binding cassette transporters (ABC) 
ABC-transporters utilize the energy of ATP hydrolysis to transport various substrates 
across cellular membranes. They are classified as ABC transporters based on the 
sequence and organization of their ATP-binding domain(s), also known as nucleotide-
binding folds (NBFs)64. It is known that ATP binding leads to dimerization of the two 
ATP-binding domains, and ATP hydrolysis leads to their dissociation. These structural 
changes in the cytosolic domains are thought to be transmitted to the transmembrane 
segments, driving cycles of conformational changes that alternately expose substrate-
binding sites to one or the other side of the membrane. ABC transporters are known to 
play a crucial role in the development of multidrug resistance (MDR)64, 65.  
 
1.2.3 Purification of membrane proteins for shotgun proteomics 
Traditional MS-based proteomic analyses utilized two-dimensional gel electrophoresis to 
separate complex protein samples66.  However, membrane proteins are normally 
underrepresented on the gel due to their alkaline and poorly soluble properties. Moreover, 
they are generally not very abundant, so that they cannot even be detected in standard 
gels66.  Bottom-up shotgun proteomics approaches based on separating digested peptides 
with HPLC prior to MS acquisition provides a powerful alternative to 2D gel based 
proteomics. Sample preparation for shotgun membrane proteomics normally includes 
soluble proteins and membrane associated protein removal, delipidation, membrane 
protein solubilization and digestion. Subcellular fractionation is also important for PM 
proteomics, one of the most interesting proteomes. High salt buffer and high pH sodium 
carbonate (or sodium hydroxide) buffer are used in nearly all membrane fraction 
preparation protocols to remove soluble and peripheral membrane associated proteins67, 68. 
The most widely used delipidation approach in the literature is methanol/chloroform 
precipitation69-71. Approaches for membrane fraction purification and membrane protein 






analysis by biochemical researchers generally concentrate on these two issues, as well as 
the separation methods for digested peptides before MS acquisition. Since the peptide 
separation is a technique issue regardless of the properties of membrane proteins, here we 
focus our discussion on fractionation and solubilization of membrane proteins. 
Furthermore, the developments of MS instruments and corresponding data analysis 
software do of course increase the data quality tremendously, as discussed in the next 
section. 
 
1.2.3.1   Fractionation of membrane protein  
Several approaches have been established for fractionation of membrane proteins, in 
particular the most interesting PM proteins. In a wide sense of the word, centrifugation is 
essential in every step of purification. Special buffered centrifugation, e.g. sucrose 
gradient centrifugation72, can be used alone for subcellular fractionation. Aqueous two-
phase systems and affinity purification are two other methods especially setup for PM 




Centrifugation separates subcellular compartments according to sedimentation velocities 
and/or buoyant densities73. By applying a well defined g-force for a certain length of time 
and suspension buffers, differential centrifugation is a rapid means for subcellular 
fractionation. A two-step differential centrifugation is widely used for crude membrane 
preparation prior to any other further subcellular purification74. In the first step, low 
speed centrifugation, e.g. 1000 g, is used to remove cell debris and intact nuclei. In the 







 Sucrose gradient centrifugation is another widely used method for different organelle 
membranes or intact organelles separation according to their buoyant density72. The 
gradient can be either a step or continuous function. Although a continuous gradient 
provides better resolution, the step gradient stacks the sample in a thin layer in the 
interface of different sucrose concentration, leading to a higher concentration and yield. 
Furthermore, compared to the continuous gradient, no gradient forming device is needed 
for the step gradient and the centrifugation time is 1h instead of 10h. The simple work 
flow and the higher yield make the step gradient more popular for large scale proteomics 
study with crude membrane preparation70, 75-81.  
Besides sucrose, which is the most commonly used gradient medium, there are other 
alternatives such as Percoll82, 83, Ficoll, Nycodenz, or glycerol (for a review see73). 
Taking Percoll as an example, the density of the mixture is chosen to be smaller than the 
particles at all points during the separation and the run is terminated before the separated 
zones reach the bottom of the tube. In one report, the membrane content of the identified 
proteins enriched by Percoll gradient was up to 60% (ref 82).  
 
Aqueous polymer two-phase systems  
The aqueous polymer two-phase system is widely used for analytical PMs purification78-
80, 84-89. If two structurally distinct water-soluble polymers are mixed above a critical 
concentration in aqueous solution, the polymers will eventually separate into two phases. 
The most commonly used aqueous polymer two-phase systems for membrane separation 
is the polyethylene glycol (PEG)/ dextran system. The partitioning behavior of the 
protein in the PEG/dextran system depends on the concentrations of the polymer. When 
the concentrations are close to the critical point of the PEG/dextran two-phase system, 
membranes tend to partition in the top PEG phase. Increase in polymer concentrations 
results in larger differences in the composition of the two phases. As a result, membranes 
tend to partition to the interface or the bottom phase. This dependency of the partitioning 
behavior on the polymer concentrations can be exploited to selectively enrich PMs in the 






hydrophobic top phase, followed by Golgi vesicles, lysosomes, the endoplasmic 
reticulum and mitochondria85. The degree of polymerization of PEG also affects the 
phase separation and the partitioning of molecules during extraction, increase of the 
molecular weight of PEG results in decreased partition of the membranes into the top 
phase, whereas increase of the molecular weight of dextran gives rise to increased 
partition of the PMs to the top phase85. In addition, salt and ligand in the aqueous system 
affect the partition behavior of membrane. Since there are so many variables affecting the 
partition behavior, application of the aqueous two-phase system requires carefully 
controlled conditions and optimization for specific tissue sources.  
The protocol for aqueous tow-phase system seems to be different from laboratory to 
laboratory, and even different with time in the same laboratory. Because the isolation of 
PMs cannot be achieved through a single-step procedure, multiple extraction procedures 
such as countercurrent distribution experiments as shown in Fig. 4 are applied84, 85. In the 
protocol shown, the PMs are enriched in the top phase of G, and the recovery is around 
18% in an optimized system85. In a simplified workflow, only the first two steps of Fig. 4 
are used78, 79. After several rounds of the protocol in Fig. 4, the PMs enriched with PEG 
can be mixed with fresh WGA (wheat germ agglutinin)-dextran, where PMs are 
selectively pulled into the WGA-dextran enriched bottom phase86.  For the optimized 
conditions as reported by Schindler et al, the recovery of PMs is 15% and the PM content 
of the identified 525 proteins is about 27-38%, depending on the prediction software and 
criteria used84. In a rat liver membrane proteomics project published by Cao et al, 23% of 
883 identified proteins were GO (gene ontology) annotated to be integral membrane 







Figure 4. Protocol example for aqueous two-phase partition. A) Tissue is homogenized 
in a two-phase system and after phase separation, the top phase is transferred onto the 
fresh bottom phase ‘B’, and the bottom phase of the primary two-phase system ‘A’ is 
covered with a fresh top phase. In the subsequent steps, the top phases are transferred one 
bottom phase along, always transferring the latest top phase onto a fresh bottom phase 
and re-extracting bottom phase ‘A’ with a fresh top phase. By doing so, one more two-
phase system is extended in each step, e.g. 10 two-phase systems (‘A’–‘J’) are obtained 
after the 8th step, each containing a top and a bottom phase. In this protocol, the PM 
proteins are enriched in the top phase of G and the calculation is based on the assumption 
that 70% PM fraction partition to the top phase and 30% to the bottom, the value is 
assumed to be opposite for contaminate membrane fraction. B) the outcome for each 
fraction illustrated with PMs in circles and intracellular membranes in squares. From 







The affinity purification of PMs utilizes the properties of different extracellular domains 
of integral membrane proteins. Two commonly used methods are biotinylation affinity 
purification90-95 and Lectin affinity purification based on glycosylation96. Compared to 
biotinylation affinity purification, no labeling procedure is needed for glycosylation 
affinity purification. The biotin group is normally reacted in situ with the ε-amino group 
of lysine, Two commercially available biotinylation reagents sulfo-NHS-SS-biotin90-94 
and sulfo-NHS-LC-biotin95 are used. Both reagents have internal disulfide bonds, which 
allow for the cleavage from the avidin resin by treatment with reducing agent. It was 
reported that the biotin affinity purification procedure was able to achieve a 1600-fold 
relative enrichment of PM versus mitochondria and a 400-fold relative enrichment versus 
endoplasmic reticulum91. The best enrichment results by biotin affinity purification 
obtained so far is 526 integral PM proteins out of 898 identified proteins, which is 58.6% 
(ref 90).  The data for glycosylation purification is very limited, and the enrichment is not 
as efficient. Although the biotinylation enrichment seems very promising for cell line 
PMs purification, it is not suitable for tissue samples. The connection between adjacent 
cells and the surrounding matrix make the PM proteins inaccessible for labeling. 
 
1.2.3.2   Solubilization and digestion of membrane proteins 
Because of the very hydrophobic properties, completely dissolving membrane proteins in 
aqueous solution is challenging. Detergents therefore play an indispensible role in 
membrane protein solubilization but, since they are not compatible with MS, they are 
routinely removed by 1 or 2D PAGE. Because of the limitations of gel based approaches, 
e.g. proteins may not be completely digested, or peptides may not be extractable from the 
gel, gel-free but detergent based proteomics would be ideal, as well as other dissolving 








Detergent solubilization  
Detergents are indispensible in membrane proteomics. Nearly all above mentioned 
projects except82, 94 used detergents as the membrane protein solubilization reagent. 
Detergents are amphipathic molecules that contain a polar group (head) at the end of a 
long hydrophobic carbon chain (tail). The majority of the lipids that make up the 
membrane contain two hydrophobic groups connected to a polar head, which can be 
viewed as biological detergents. Detergents solubilize membrane proteins by mimicking 
the lipid-bilayer environment. The critical micelles concentration (CMC) is an important 
parameter to be taken into consideration when using detergents. CMC is defined as the 
concentration of detergents above which micelles are spontaneously formed. Therefore, 
by applying detergents at a concentration above the CMC, hydrophobic regions of 
membrane proteins, normally embedded in the membrane lipid bilayer, are now 
surrounded by a layer of detergent molecules and the hydrophilic portions are exposed to 
the aqueous medium. This micelle structure keeps the membrane proteins in solution.  
Based on the nature of the hydrophilic head group, detergents can be broadly classified as 
ionic, non-ionic, and zwitterionic detergents, which are exemplified by SDS, Triton and 
CHAPS respectively. Different detergents may have different preferences in dissolving 
different group of membrane protein, but so far no directly comparison of applying 
different detergent in the proteomics area has been reported. Normally researchers choose 
the detergent according to their own experience or sometimes make use of a combination 
of different groups of detergents. Since even a small concentration of a detergent 
completely dominates mass spectra and precludes peptide or protein analysis, detergents 
have to be efficiently and thoroughly removed from proteins or peptides in MS-based 
proteomics analysis.  Different  methods have been described for separation of proteins 
from detergents including gel filtration, ion-exchange and hydrophobic adsorption 
chromatography, density gradient centrifugation, dialysis, ultra filtration, phase partition, 








Organic solvent solubilization  
Another alternative way to dissolve or extract membrane proteins is by performing 
intermittent vortexing and sonication in 60% organic solvent (e.g. methanol94, 99-101). 
Trypsin digestion is immediately carried out in the organic-aqueous solvent mixture. The 
total number of identified proteins in the above studies range from 117 (ref 101) to 786 
(ref 94).  In the best isolations, 42% proteins have at least one transmembrane domain. 
One paper reports that organic solvent solubilizes membrane protein more efficiently 
than SDS102. However, since only 299 proteins were identified in that experiment using 
SDS extraction, the protocol itself is clearly not optimal.  
 
Acid solubilization.  
A high concentration (up to 90%) of formic acid was also reported to be effective in 
solubilizing membrane proteins103.  In this method, cyanogen bromide (CNBr) is used to 
cleave many embedded membrane proteins at the C-termini of methionine under acidic 
conditions. Formic acid is used instead of hydrogen chloride (0.1M) because it dissolves 
most proteins and its reductive property keeps methionine from oxidation, which is inert 
to CNBr attack. Formic acid causes the formation of formyl esters to serine or threonine – 
a potential problem for further analysis. The large fragments from CNBr cleavage are 
digested with Lys-C or trypsin to obtain a suitable length for mass spectrometric analysis.  
 
On membrane digestion.  
Beyond the above mentioned methods, in which protein digestions are done after 
dissolving the proteins in different buffers, on-membrane digestion was also reported. 
Whereas proteinase K is used to cleave exposed soluble domains of integral membrane 
proteins at high pH104, Lys-C has also been shown to digest proteins ‘on membrane’ 
when using 4M urea82.  In Wu et al, whole brain homogate was digested with proteinase 






have at least one transmembrane domain104. In our group’s work digestion of PM 
fractions after percoll sedimention in total resulted in 1685 protein identifications, of 
which the membrane proteins content was 60%  (ref82).  
 
When membrane proteins are digested, the peptides are further separated by 
chromatography prior to MS analysis. Multi-dimensional HPLC can also be applied. The 
MS instruments are different from laboratory to laboratory, and the algorithm for MS 
data analysis can be also different. All of the post-membrane fractionation strategies may 
affect the final data quality. Therefore, it is difficult to base comparison of different 
purification and solubilization methods for membrane proteomics on the number of 
identified proteins alone. The proportion of membrane proteins should give a more direct 
evaluation of the fractionation protocol. However, care still needs to be taken because 
different transmembrane prediction algorithm or different database annotations may give 
















1.3 Mass spectrometry based proteomics 
Proteomics is a collective term for large-scale approaches to protein science105. Modern 
proteomic methods include mass spectrometry, protein microarrays, large-scale two-
hybrid analyses, high-throughput protein production and crystallization105. Since the 
development of two soft ionization methods, electrospray ionization (ESI)106 and matrix-
assisted laser desorption/ionization (MALDI)107, MS has gradually become the most 
popular platform to study protein expression, post-translational modifications and 
interactions. Recent progresses of MS instrumentation and data analysis software, 
together with different quantitation methods, not only enable close-to-complete proteome 
measurements, but also acquire high-content quantitative information about biological 
samples of enormous complexity108. 
 
1.3.1 General workflow of MS-based bottom-up proteomics 
Proteomics is able to handle different sample mixture or different sub-fractions of 
interesting sample in batch. Both proteins and peptides can be analyzed directly by MS, 
which is named top-down and bottom-up proteomics, respectively. Top-down proteomics 
(reviewed in109) measures the molecular weight of intact proteins, and therefore can in 
principle provide complete information of post-translational modifications. It is 
especially suitable to analyze the proteins with all PTMs in a certain state or PTM 
dynamics during different cell states109. With increasing molecular weight, top down 
analysis becomes more and more difficult. It requires more complex instrumentation and 
expertise when the molecular weight is greater than 20 KDa. Only a few groups in the 
world have reported identification of more than a few proteins by top-down in one study 
109. Furthermore, automated hardware and software dedicated to top-down approaches are 
currently in an underdeveloped state109, which makes high throughput and routine 
analysis impossible. Compared to top-down, bottom-up proteomics identifies proteins 
regardless of the intact mass of proteins. Digested peptides can be easily ionized, and 






requires 1–2 orders of magnitude less material than top-down109. Bottom-up proteomics 
is much more competitive in analyzing complex biological mixture. 
 
A typical workflow of MS-based bottom-up proteomics is depicted in Fig. 5. Different 
tissue samples, cell cultures or body fluids can be analyzed. After tissue homogenization 
or cell harvest, the crude mixture normally needs to be purified in order to remove 
contaminating nucleic acids, fat, detergent etc, or subfractionated in order to increase the 
dynamic range of identification. Isolated protein samples are cleaved by endoproteinase, 
typically by trypsin or lys-C. After digestion, the peptide mixture is desalted, for example 
by C18 reverse phase StageTips110. To increase the dynamic range, peptides are loaded on 
an HPLC system, and the separated peptides from chromatography are directly sprayed 
into the MS instrument for data acquisition. The typical flow rate of the HPLC is 200 – 
500 nl/min. Raw data files containing the information of ion current intensity and MS and 
MS/MS spectra are analyzed by bioinformatics software to extract MS and MS/MS lists. 
The files containing the lists are searched against the in silico predicted spectra from 
sequence databases by search engines such as MASCOT or SEQUEST. Proper 
modifications, cleavage enzyme, and maximum mass deviation for precursor and 
fragmentation ions should be defined before the search. By setting some confidence 
criteria, a list of interesting proteins can be obtained. The protein list is not the end 
product of proteomics. With a suitable experiment setup, the inventory may contain 
information about protein subcellular localization, function in signaling pathways, or 
protein-protein, protein-nucleic acid interactions, which then needs to be validated by 







Figure 5. General workflow of MS-based bottom-up proteomics. Samples from tissue or 
cell culture are homogenized and fractionated for endoprotease digestion. Peptides are 
separated by on-line HPLC and analyzed by mass spectrometry. The MS and MS/MS 
lists extracted from MS raw files are searched against protein sequence databases. By 
setting certain criteria depending on the experiment setup, a list of confident protein 
identifications is obtained. The functions of interesting protein need to be validated by 
other biochemical methods. 
 
1.3.2 MS instruments 
A mass spectrometer is an instrument that measures the mass-to-charge ratio (m/z) of gas 
phase ions. Every mass spectrometer nowadays consists of an ion source, at least one 
mass analyzer and detector, and the data system. Since only ions in gas phase can be 
analyzed in a MS, protein or peptide ions have to be evaporated in the ion source,  
typically by one of two soft ionization methods: electrospray ionization (ESI)106 and 
matrix-assisted laser desorption/ionization (MALDI)107. Ions are separated in the mass 
analyzer according to either their momentum in a magnetic sector111, kinetic energy in 















in linear quadrupoles114 and quadrupole ion traps115, and frequency in  and ion cyclotron 
resonance (ICR) mass spectrometer116 as well as Orbitrap mass spectrometer117. Finally, 
ions are registered under high vacuum conditions in detectors and signals are converted 
to a readable or graphic display by the data system. Often the electron signals are 
multiplied via a secondary electron multiplier. 
 
Standard parameters to evaluate a mass spectrometer include resolution, mass accuracy, 
mass range or upper mass limit, and ion dynamic range118.  
 
1.3.2.1   Ionization 
Although the first MS was constructed by J.J. Thomson in 1912 (ref 119), the introduction 
of MS to biological research was not successful until late 1980s, when the two most 
popular soft ionization methods ESI and MALDI were developed. 
 
Electrospray Ionization (ESI) 
The idea of using electrospray dispersion to produce gas phase ions from solution was 
first introduced by Dole and colleagues in 1968 and later applied to large biomolecules 
by Fenn and his co-workers in 1989, with the discovery that large molecules produce 
multiple charged ions in the electrospray ion source106. This technique was further 
improved by Mann and coworkers by introducing nanoelectrospray ionization (nanoESI) 
compatible with nano-flow rates for minute amount of samples120, which highly increase 
the detection sensitivity. 
By using electrospray ionization, the analyte solution is placed or pumped inside a fine 
capillary or needle, to which either a positive or negative high voltage is applied to 
produce an electric field. The direction of the electric field gradient is dependent on the 
analytes with the ion potential decreasing along the spray direction. Anions and cations 
are separated on the surface of the liquid and charges accumulate at the end of the needle. 






(Fig. 6)121. When the Coulombic repulsion between the accumulated charges is equal to 
the surface tension of the liquid, tiny droplets that contain the excess positive or negative 
charges detach from the tip and move towards the opposite lens. As the droplets move, 
more and more solvent evaporates and gradually the droplets become so small that each 
one contains only a single solute molecule (according to the Dole ’charged residue’ 
mechanism106). 
 
Figure 6. Schematic presentation of the electrospray process for positive charged ions. 
High potential applied between the needle and the lens forces the highly charged droplets 
to detach from the tip of the needle. As the droplets travel to the lens, analytes become 
ionized due to the evaporation of the solvent. The picture is from Wiśniewski122. 
 
Matrix Assisted Laser Desorption/Ionization (MALDI). 
Lasers have been used to generate ions in mass spectrometers since the early 1960s123. 
Early studies of biomolecules with lasers had a mass limitation at about 200 Da, because 
direct irradiation by the laser is destructive to the thermolabile analytes. A breakthrough 
for laser ionization came when Karas and Hillenkamp reported the use of matrix assisted 
ultraviolet laser desorption for non-volatile compounds in 1987 (ref107), with which it is 
possible to analyze large, nonvolatile biomolecules, such as peptides, proteins, 
oligonucleotides, and oligosaccharides. 
In MALDI, the analytes are dissolved in high organic solvent together with matrix, and 






embedded throughout the matrix so that they are completely isolated from one another 
(Fig. 7). One mechanism to explain the ionization mechanism is that, when crystals are 
irradiated by the laser, the matrix is excited and expanded into the gas phase, entraining 
intact analyte in the expanding matrix plume (Fig. 7)124. Little internal energy is 
transferred to the analyte molecules and they may even be cooled during the expansion 
process. Ionization reactions can occur at any time during this process. Although no 
unified model exists, it is believed that analyte ions are formed by either proton or 
electron transfer from or to matrix ions. The reactions maybe very complex and matrix 




Figure 7. Schematic overview of MALDI source. Analytes are embedded evenly in 
matrix crystal and entrained into matrix plume when irradiated by laser.  
 
 
1.3.2.2   Linear ion trap (LTQ) 
The basic construction of a commercial linear ion trap, the LTQ, is depicted in Fig. 8. 
The rods of the quadrupole structure have hyperbolic profiles and are cut into three axial 
sections, with the length of the central section around three times that of the other two 
sections. Applying the proper direct current (DC) to three sections allows trapping of the 
ions along the axis in the central section of the device. Radial trapping of the ions is 






pairs and ion isolation, activation and ejection is achieved by applying two phases of 
supplemental alternating current (AC) voltage across the X rods125.  
The LTQ can perform MS analysis alone or work together with other analyzer as a hybrid 
mass spectrometer. Compared to the 3D Paul trap, LTQ has the advantages of increased 
ion storage capacity and improved trapping efficiency. Compared to the FT-ICR (Fourier 
transform ion cyclotron resonance) and the orbitrap described below, it has high 
sensitivity and fast acquisition, typically 3,000-5,000 ions are enough for LTQ to get 
good signal within a few milliseconds, while for FT-ICR and orbitrap, normally 
1,000,000 ions are necessary and the scanning time is nearly 1 second for each spectrum. 
But the sensitivity and fast acquisition comes at the expense of low resolution and less 
accuracy. 
 
Figure 8. Basic design of the two-dimensional linear ion trap. From Schwartz J.C. et al125. 
 
1.3.2.3   Fourier transform ion cyclotron resonance (FT-ICR) 
The fundamental principle of FT-ICR is the motion of a charged particle in a spatially 
uniform magnetic field126. An ion injected in the plate perpendicular to the direction of 
magnetic field without any collision with a velocity v, will move in a circle of a radius  
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where B is the magnetic field strength, q is the ion charge, m is the ion mass. A 
remarkable feature in the above equations is that the ICR frequency f is independent of 
their velocity. Therefore, ions of a given mass-to-charge ratio have the same ICR 
frequency regardless of their initial energy. The insensitivity of the cyclotron frequency 
to the kinetic energy of an ion is one of the fundamental reasons why the FTMS 








Figure 9. Electronic circuit for ion excitation 126.  
 
Single ion excitation 
An ion’s initial room temperature thermal cyclotron radius shown as equation (2) is 
typically on the order of 100 µm, which is too small to be observed127. A spatially 
uniform electrostatic field oscillating sinusoidally at the same frequency of ions of 
interest is applied perpendicular to the magnetic field to excite ions, along the x-axis (Fig. 
9). The post-excitation ion cyclotron radius (r) and kinetic energy (KE) can be calculated 
by 
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Where Vp-p is the peak-to-peak voltage difference between the two plates along x-
direction, and d is the distance between two plates, Texcite is the oscillating resonant 
excitation duration126. Equation (3) shows that the post-excitation ion cyclotron orbital 
radius is independent of m/z. Thus, all ions of a given m/z range can be excited to the 
same ICR orbital radius by application of an RF electric field whose magnitude is 
constant with frequency. In contrast, equation (4) shows that, for a given excitation 
electric field amplitude and duration, post-excitation ion kinetic energy is independent of 
magnetic field strength B. Combing equation (3), we can see that, if we want to excite 
ions to a give radius, the post-excitation energy increases proportional to the square of B.    
Broadband excitation 
Broadband excitation in FTICR is performed in SWIFT mode, where SWIFT stands for 
“stored waveform inverse Fourier transform”. SWIFT waveforms start by defining the 
mass-domain of desired excitation profile, and then convert it to a frequency-domain 
spectrum, by performing an inverse Fourier transform to generate the desired time-
domain excitation waveform126. A combination of ion excitation and ion ejection can be 
achieved simultaneously by SWIFT waveforms.   
 
Ion detection 
All ions of the same m/z are excited coherently, and undergo cyclotron motion as a 
packet. When the ion packet passes the two detection plates alternatively, a sinusoidal 
image signal is produced, which can be amplified, digitized and stored for processing by 
a computer. Ions of many masses can be detected simultaneously with FTMS. The 
maximum resolution that can achieved for a data set is  
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FTICR MS is the instrument that can provide the best mass accuracy and highest mass 
resolution so far. By using a 14.5 magnet, it is possible to achieve external calibration 
broadband mass accuracy less than 300 ppb rms, and a resolving power of 200,000 at m/z 
400 (ref 128).  
 
1.3.2.4  Orbitrap 
The orbitrap is an ion trap that traps ions in an electrostatic field, instead of RF or magnet 
fields129. The trap consists of an outer barrel-like electrode and a central spindle-like 
electrode along the axis (Fig. 10). The outer electrode is split at the middle allowing ions 
to be injected into the trap. A DC voltage is applied between the outer and inner 
electrodes.  
 
Figure 10.   Cut-away structure of the Orbitrap mass analyzer. From Scigelova et al129. 
 
Both electrodes are specially shaped, and the axially symmetric electrodes create a 
combined “quadro-logarithmic” electrostatic potential: 
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Where r and z are cylindrical coordinates, k is a constant,  and Rm is the characteristic 
radius 117. Stable ion trajectories involve both an orbiting motion around the central 
electrode and simultaneous oscillations in the z-direction. The potential in the z-direction 
is exclusively quadratic. Ion mass/charge ratio m/z is simply related to the frequency of 
ion oscillation along the z-axis 
                                                            ω ൌ ඥሺz m⁄ ሻ ൉ ݇                                                      ሺ7ሻ              
This axial frequency is used for ion detection, because it is completely independent of 
energy and of the spatial spread of the ions117. This feature in analogy to FTICR, is a 
fundamental reason for ultra-high resolution. 
 The orbitrap is another instrument, besides FTICR MS, that can provide very high mass 
accuracy and mass resolution. By applying a ‘lock mass’ for internal calibration, sub-ppm 
(rms) mass accuracy were achieved130. High-mass resolution up to 150,000 for ions 
produced by laser ablation has been demonstrated131.   
 
1.3.2.5   Hybrid mass spectrometers 
As mentioned above, the LTQ analyzer has the advantages of high sensitivity and fast 
scanning, while FT-ICR and orbitrap have unparalleled high mass accuracy and 
resolution. Thermo Fisher, a manufacturer of mass spectrometers, combined the 
advantages of both to create the hybrid LTQ-FT and LTQ-Orbitrap, which are the 
instruments on which all experiments in the study were performed. 
The configuration of the LTQ-FT and LTQ-Orbitrap is shown in Fig. 11. For normal 
shotgun proteomics analysis, survey scans are acquired in either FT or orbitrap, while 
MS/MS spectra are acquired in the LTQ. For some special purposes, e.g. post-
translational modifications analysis or de-novo sequencing, MS/MS can be also acquired 








Figure 11. A schematic of the hybrid instruments: a) LTQ-FT (from Schrader et al132), b) 
LTQ-Orbitrap (from Scigelova et al129). 
 
1.3.2.6   Peptide fragmentation 
Nomenclature 
The nomenclature of peptide fragment ions adopted nowadays is suggested by Roepstorff 
and Fohlman in 1984 (ref 133) and modified by Biemann in 1988 (ref 134). There are three 






in the peptide main chain. According to this nomenclature, the fragment ions are labeled 
an, bn, cn when a positive charge is kept by the N-terminal side and xn, yn, zn when the 
positive charge is kept by the C-terminal side (Fig. 12). There are two extra hydrogen 
atoms transferred to cn and yn ions, one responsible for the protonation and the other one 
originating from the other side of the peptide, but not for an, bn, xn, zn ions. The subscript, 
n, indicates the number of amino acid residues contained in the fragment ion.  
There is a marked difference between the fragmentation observed at high and low CID 
energy124. At low energy, the observed fragments are mostly bn and yn. At high energy, 
all the possible fragments can be generated. Besides that, multiple cleavages occur. There 
are two types of informative multiple cleavage fragments. One is the immonium ion, 
which results from multiple cleavage of the peptidic chain and appears among the low 
masses in the spectrum. They yield information concerning the amino acid composition 
of the peptide. The other type results from the cleavage of the peptidic chain and amino 
acid lateral chain. There are three observed types of fragments, termed dn, wn, vn 
respectively, as shown in the middle part of Figure 15. dn and wn result from the cleavage 
of the bond between the β and γ carbon atoms of the side chain of the C-terminal amino 
acid or of an N-terminal amino acid of zn respectively, and are useful to distinguish the 
isomers Leu and Ile. vn results from the complete loss of the side chain of the N-terminal 







Figure 12. Illustration of nomenclature for peptide fragment ions. a) fragments results 
from the cleavage of a bond in the peptide chain; b) fragments result from double 
cleavage of both the peptidic chain and amino acid lateral chain; c) the structure of 
immonium ions. The nomenclature was proposed by Roepstorff and Fohlman in 1984 
(ref 133) and modified by Bieman in 1988 (ref 134). 
 
Collision-induced dissociation (CID) 
In traditional metastable analysis using magnetic sector instruments, the ions leaving the 
source can be classified into three categories: (1) stable ions, with a lifetime greater than 
10-6 s, reach the detector before any fragmentation has occurred; (2) unstable ions, with a 
lifetime smaller than 10-7 s, fragment before leaving the source; (3) metastable ions, with 
an intermediate lifetime, are stable enough to be selected by the first analyzer and 
fragment before they reach the second analyzer. CID converts part of the kinetic energy 
of ions into internal energy by collision with inertial gas, and thus shorten the lifetime of 
precursor ion from type (1) to type (3). 
By applying the energy and momentum conservations in the collision process, the 
maximum energy fraction that can be converted into internal energy is given by the 
following equation124:  
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Where Mi is the ion mass, Mt is the collision gas mass, Elab is the ion kinetic energy and 
Ecm is the maximum energy fraction converted into internal energy.  
Two collision regimes should be distinguished: low-energy collision with collision 
energy between 1 and 100 eV, occurs in quadrupole or ion trap instrument; and high-
energy collision with ~keV collision energy, occurs in electromagnetic or TOF 
instrument. The fragmentation patterns observed for low and high collision energy is 
different. Low energy CID produces fragmentation at the peptide bonds, whereas high 






High-energy C-trap Dissociation (HCD) 
HCD is a fragmentation technique that is special to the LTQ-Orbitrap instrument135. As 
shown in Fig. 11b, the C-trap is normally used to store ions on their way from the ion trap 
to high-resolution analysis in the orbitrap. After applying RF voltage, ions can be 
fragmented inside the C-trap and further transfered to the orbitrap for acquisition. 
Compared to the normal CID fragmentation acquired in the LTQ, it has the advantage of 
high mass accuracy and high resolution. Furthermore, it contains the fragmentation in the 
low-mass region, which is less than one third of the precursor ion and is normally missing 
in CID MS/MS spectra obtained in an ion trap. Higher energy is applied compared to 
CID, therefore, HCD produces immonium ions, which can be used as a diagnostic peak 
for certain amino acids or modification. This technique is especially useful for post-
translational modifications or de-novo sequencing analysis. For example, trimethylation 
and acetylation with a mass difference of 0.0364 Da can be differentiated by HCD. 
 
1.3.3 Quantitative Proteomics 
Proteins are the functional units of biological processes. Cells organize different cellular 
events not by just turning protein expression on and off, but by precise regulation of 
protein levels in space and time. Taking tissue differentiation as an example, only a small 
fraction of all proteins are thought to be expressed in only one tissue136. Therefore, 
protein identification is often not sufficient to decipher different biological phenomenon, 
whereas quantitative proteomics can yield function from relative protein levels. . 
Unlike other proteomics methods which utilize dyes, fluorophores or radioactivity for 
quantitation, MS-based proteomics quantitation is based on labeling, which can be either 
metabolic labeling or chemical labeling (Fig. 13). Recent developments of MS data 
analysis software make label free quantitation possible. Absolute quantitation can also be 







Figure 13. Common quantitative mass spectrometry workflows. Boxes in blue and 
yellow represent two experimental conditions. Horizontal lines indicate when samples are 
combined. Dashed lines indicate points at which experimental variation and thus 
quantification errors can occur. From Bantscheff M. et al138. 
 
Metabolic labeling 
Metabolic labeling introduces a stable isotope signature into proteins during cell growth 
or division, therefore, it allows mixing different samples at the level of intact cells, which 
eliminates the errors introduced during differential sample preparation. This type of 
labeling was initially described for total labeling of bacteria using 15N-enriched cell 
culture medium139, however, the uncertain number of N in different peptides make 
quantitation extremely difficulty.  The introduction of the stable isotope labeling by 
amino acid in cell culture (SILAC)140 made metabolic labeling very popular and the most 






The amino acids chosen for SILAC labeling should be essential for the cell line.  Lysine 
and arginine are the two most common targets for labeling, which together with the 
popular trypsin digestion for proteomics, ensures every peptide except the C-terminal one 
can in principle be used for quantitation. SILAC labeling utilizes arginine and lysine with 
heavy elements of 13C, 15N, and 2H. The most commonly used forms are 13C6-Arg, 
13C615N4-Arg, 2H4-Lys and 13C615N2-Lys. Up to three different biological conditions can 
be directly compared in a single SILAC experiment (Fig. 14) and the number of different 
conditions for comparison can be extended indirectly141.  
The quantitation in SILAC experiments is normally done by comparison of the extracted 
ion current (XIC), which is the integrated value of a mass-specific signal in the LC MS 
data137. One advantage of SILAC labeling with 13C atoms is that the light- and heavy- 
labeled peptides co-eluted very well137, which minimizes artifacts due to pairing wrong 
peptides.   
SILAC based quantitation has proven to be powerful for many interesting biological 
discoveries142. The only limitation is that it is not feasible for in vivo tissue sample 
analysis of large mammals such as humans.  
 


















Chemical labeling can be performed either on the intact protein level or at the peptide 
level. Reported methods for chemical labeling protein or peptide are quite diverse (for 
reviews see137, 138), including isotope-coded affinity tags (ICAT)143, HysTag144 or isotope 
tags for relative and absolute quantification (iTRAQ)145. ICAT is the first chemical 
labeling method that was widely used. The reagent consists of three elements: an affinity 
tag (biotin), which is used to isolate ICAT-labeled peptides; a linker that can incorporate 
stable isotopes; and a reactive group with specificity toward thiol groups (cysteines). 
Therefore, labeling by ICAT can be used both for affinity purification and quantitation. 
The same is true for the HysTag, which consists of four functional elements: i) an affinity 
ligand (His6-tag), ii) a tryptic cleavage site (-Arg-Ala-), iii) an Ala-9 residue that contains 
four (d4) or zero (d0) deuterium atoms, and iv) a thiol-reactive group. iTRAQ is a 
multiplexed set of isobaric reagents that modify the amino terminus or the side chain of 
lysines of each peptide. The complete molecule consists of a reporter group, a mass 
balance group which makes the overall mass of reporter and balance group constant, and 
a peptide-reactive group. Differently modified peptides have the same m/z in the MS 
spectra but in MS/MS spectra, the unique low-mass reporter ion of each tag (113-121 Da) 
from different status is available for quantitation. iTRAQ does not provide  enrichment, 
however, it has the powerful advantage that up to 8 different samples can be directly 
compared in a single experiment146. The disadvantages of all the chemical labeling 
approaches compared with SILAC are that the samples are combined at a relative late 
state, and that the labeling procedure may introduce manual errors. 
 
Label free quantitation 
Label free quantitation compares the XIC value of the same peptide in different 
chromatography runs, based on their mass and retention time147, 148. The straightforward 
experimental protocol and the fact that in principle  any samples can be compared to each 
other make label free quantitation attractive138. For a reliable comparison, label-free 






systems122. The sample preparation steps should be minimized, and all samples should be 
prepared in parallel, injected into the MS identically one after another to reduce possible 
errors. The temperature of the chromatography column should be controlled carefully to 
make the elution time for the same peptide identical. High mass accuracy and high mass 
resolution MS instruments and reliable data analysis software are also necessary to obtain 
reliable results137. Elution time alignment and intensity normalization may be necessary 
to improve the data accuracy. 
 
Absolute quantitation 
All three above mentioned approaches quantify proteins relatively in different samples. In 
principle, if we change one of the samples to a known amount of isotope-labeled standard 
which resembles the protein/peptides of protein to be quantified, it is possible to obtain 
the absolute amount of the protein of interest. Several methods are now available for MS-
based absolute quantitation. Culture-derived isotope tags (CDITs)149 quantify tissue 
samples taking the advantage of SILAC by mixing labeled cells with brain samples. 
Synthetic unlabeld peptides were spiked into the cell mixture for absolutely quantifying 
brain samples indirectly. In another method, termed Absolute Quantitation (AQUA)150, 
synthetic peptides incorporated with stable isotopes are spiked into samples as an internal 
standard. Post-translational modification can also be incorporated, thereby, modification 
induced ionization differences can be eliminated.  Both CDITs and AQUA utilize 
synthetic peptides as an internal standard for absolute quantitation.  Peptides should be 
synthesized specially for every interesting protein. While these methods can accurate 
quantify the peptide amount after digestion, the sample loss during the preparation steps 
before digestion is in principle not known. In a third method QCAT151, a tryptic and His 
tag containing Q peptides is constructed to be a concatemer of one peptide from every 
interesting proteins. A gene coding for the Q peptide is insert to E. coli by vector.  After 
cloning in 15N medium, the Q peptide is purified and combined with samples as a 
standard. By using QCAT, peptides do not need to be synthesized individually for every 






peptides can be spiked into samples earlier than the other two methods, which could also 
reduce systematic errors. 





2 Aim of this study 
The projects involved in this thesis were conducted with the aim to improve technologies 
for (1) individual protein characterization (2) global membrane protein identification.  
For a comprehensive analysis of post-translational modifications of a specific protein, 
100% sequence coverage is in principle a pre-requisite to cover all the possibilities, 
which remains a challenging task. In the first project, we analyzed peptides by a chip 
implementation of nanoelectrospray, coupled to an LTQ-Orbitrap, with the goal to obtain 
high sequence coverage at low protein concentration. In the second project, this method 
was applied to characterize different linker histone 1 variants and to identified and 
quantify the occupancy ratio of different methylation sites.  
Modern proteomics is able to identify several thousand proteins in single experiment, 
however, the identified membrane proteins are typically underrepresented compared to 
the protein sequence database. Detergents are an indispensible tool to dissolve membrane 
proteins, however, they ruin MS analysis even at minute amounts. In the third project we 
set up a detergent-based but gel-free protocol for membrane protein purification and we 
further combined the method with gel filtration chromatography in the fourth project to 
perform comparative membrane proteomics analysis for rat cerebellum, spinal cord and 
sciatic nerve.  





3 Peptide mapping by static nanoelectrospray 
 
3.1 Publication: Nanoelectrospray peptide mapping revisited: Composite survey 
spectra allow high dynamic range protein characterization without LCMS on an 
orbitrap mass spectrometer 
 
This paper presents the results for peptide mapping by using an electrostatic spray robot 
called TriVersa coupled with LTQ-Orbitrap. The following pages contain the paper 
published on International Journal of Mass Spectrometry 268 (2007): 158-167.  
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Abstract
Mass spectrometric (MS) determination of the primary structure of proteins, including post-translational modifications, remains a challenging
task. Proteins are usually digested to tryptic peptides that are measured either by MALDI peptide mapping or by liquid chromatography online
coupled to tandem MS (LC–MS/MS). Here we instead analyze peptides by a chip implementation of nanoelectrospray (TriVersa Nanomate, Advion
Biosciences), coupled to a linear ion-trap–orbitrap hybrid instrument (LTQ-Orbitrap, Thermo Fisher). The C-trap connecting the linear ion-trap
and orbitrap is filled repeatedly in different m/z ranges with up to a million charges. Each range is analyzed in the orbitrap repeatedly and separately,
creating a survey spectrum composed of hundreds of single spectra. The composite spectrum is inherently normalized for different m/z ranges due
to their different fill times and retains information on the variability of mass measurement and intensity. Nanoelectrospray offers analysis times
of more than 30 min/l of peptide mixture, sufficient for in-depth peptide characterization by high resolution C-trap fragmentation in addition to
high sensitivity ion-trap fragment analysis. We obtain over 6000-fold dynamic range and subfemtomole sensitivity. Automated analysis of digested
BSA resulted in sequence coverage above 80% in low femtomole amounts. We also demonstrate identification of seven modified peptides for a
purified histone H3 sample. Static spray allows relative quantitation of the same peptide with different modifications. Chip-based nanoelectrospray
on an orbitrap instrument thus allows very high confidence protein identification and modification mapping and is an alternative to MALDI peptide
mapping and LC–MS/MS.
© 2007 Elsevier B.V. All rights reserved.
Keywords: LTQ-Orbitrap; Peptide mass mapping; Peptide sequencing; Dynamic range; Protein modification
1. Introduction
During the last few years, efforts in mass spectrometry-based
proteomics [1] have concentrated on the qualitative and quan-
titative analysis of complex protein mixtures. However, most
biological mechanisms involve protein modifications, which are
not easily or comprehensively picked up in these large-scale
experiments [2,3]. In contrast to the few peptides required for
identification by MS, the analysis of post-translational modifica-
tions (PTMs) in principle requires peptides covering every part
of the protein (100% sequence coverage). Furthermore, some
∗ Corresponding author. Tel.: +49 89 8578 2778; fax: +49 89 8578 2219.
E-mail address: mmann@biochem.mpg.de (M. Mann).
modifications may be sub-stoichiometric, even in the purified
protein of interest, requiring the analysis of several peptides
covering the same sequence stretch.
MALDI Time-Of-Flight (TOF) and MALDI-TOF/TOF are
popular methods to identify gel-separated proteins. MALDI
sample preparation has been optimized and is rapid and conve-
nient [4]. MALDI-TOF/TOF has been increasingly automated
and now allows large number of gel spots to be identified,
i.e., in combination with 2D gel electrophoresis. Nevertheless,
the trend towards mixture analysis and quantitative proteomics
have made LC–MS/MS ‘shotgun’ methods increasingly popular
[5–7]. In particular, the quality of MS/MS data in LC–MS/MS
often makes protein identifications much more specific than with
the MALDI method [8]. Further advantages of LC–MS/MS are
its high sensitivity as peptides are concentrated into very small
1387-3806/$ – see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.ijms.2007.05.006
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peak volumes and the extra information contained in the chro-
matographic retention time of each peptide. Disadvantages are
the dynamic nature of LC–MS/MS, which makes it difficult to do
repeat measurements of the same peak as well as to apply several
fragmentation techniques during the elution time of typically
less than 30 s.
In theory, nanoelectrospray [9,10] which is static and allows
directed measurements offers a compromise allowing both ready
identification of proteins without LC separation while still offer-
ing extremely high accuracy protein identification and mapping
of post-translational modifications. The original ‘manual’ nano-
electrospray has now largely fallen out of favor, mainly because
of its low throughput. However, recently nanoelectrospray has
been revived in a chip-based form, commercially in the form of
the Advion TriVersa Nanomate. Here we investigate the combi-
nation of this automated nanoelectrospray with a powerful new
mass spectrometer, the hybrid linear ion-trap–orbitrap [11].
2. Experimental
2.1. Sample preparation for protein standards
Unless otherwise specified, chemicals were from Sigma
Aldrich. Bovine serum albumin (BSA, 2 mg/ml Bio-Rad) was
diluted to a concentration of 4 pmol/l with 6 M urea/2 M
thiourea, incubated in 1 mM DTT (final concentration) for
45 min at 56 ◦C for protein reduction and subsequently in
5.5 mM iodoacetamide (final concentration) at room temper-
ature in the dark for 30 min for alkylation. The solution was
digested with 1:50 (w/w) protein amount of endoproteinase Lys-
C (Wako) for 4 h at room temperature, then diluted 4× with
50 mM NH4CO3 and digested further with 1:50 (w/w) protein
amount of trypsin (Promega) overnight at 37 ◦C. The digestion
was stopped by adding 1% (v/v) of absolute TFA. BSA pep-
tides were desalted and stored on RP-C18 StageTip columns
[12] and eluted right before mass spectrometric analysis with
50% methanol/0.5% formic acid.
2.2. Histone H3 sample preparation
CompleteTM proteases inhibitors (Tablet, Roche) were added
to all buffers below and the solutions were cooled to 4 ◦C
before use. Semi-confluent HeLa cells were collected and resus-
pended in Buffer-N (15 mM Hepes–KOH pH 7.6, 60 mM KCl,
15 mM NaCl, 0.5 mM EGTA, 10% Sucrose). Lysis was per-
formed by adding 0.2% NP40 and rotating the cell suspension
for 10 min at 4 ◦C. Cell lysates were carefully poured on 20 ml
sucrose cushions (20% sucrose in Buffer-N). Nuclear pellets
were fractionated upon centrifugation (4000 rpm, 15 min, 4 ◦C)
and washed in PBS. Core histones, together with linker histones
and high mobility group proteins (HMG) were then extracted
by adding a half volume of ice-cold HCl (0.8 M) overnight with
continuous rotation at 4 ◦C. The sample was centrifuged for
10 min at 12,000 × g, and histones and the other acid-soluble
proteins remained in the supernatant. Residual histones were
re-extracted for 3–4 h in 0.4 M ice-cold HCl, the supernatants
derived from the two extractions were pooled and dialyzed
against 100 mM ice-cold acetic acid. The dialyzed sample was
aliquoted, lyophilized, and evaluated for purity and concentra-
tion by resuspension in H2O and by performing SDS-PAGE
(18%).
About 100g histone sample was resuspended in 100l
0.1% TFA, 2% ACN and directly loaded onto a reverse phase
HPLC column (Jupiter C18, 250 × 4.60, 5m, 300 A˚) (Phe-
nomenex) connected to an Aekta LC-system (Amersham).
Individual histones were separated by applying a gradient from
20% to 80% ACN in 0.1%TFA.
The total amount of histone H3 was estimated by SDS-PAGE.
A fraction containing 1.5g of histone H3 was dried down
and redissolved in a buffer composed of 100 mM Tris–HCl,
10 mM CaCl2, pH 7.6 for overnight Arg-C (1:50, w/w) diges-
tion at 37 ◦C. One half of the peptide solution was desalted and
stored using RP-C18 StageTip columns, while the other half
was desalted and stored using SCX (Strong Cation Exchange)
StageTip columns. Peptides on the RP-C18 column were eluted
by 50l 80% acetonitrile/0.5% acetic acid, and the peptides on
the SCX column were eluted by 50l 5% ammonium hydrox-
ide/30% methanol. Both eluates were combined, dried down,
and redissolved in 50% methanol/0.5% formic acid (1 pmol/l
or 15 ng/l) for nanoelectrospray.
2.3. Mass spectrometric analysis
All experiments were performed using a linear ion-
trap–orbitrap hybrid mass spectrometer (LTQ-Orbitrap, Thermo
Fisher Scientific, Bremen, Germany) with a TriVersa Nanomate
(Advion Biosciences, Ithaca, USA) as ion source. A positive
voltage (1.5 kV) is applied on the chip while the mass spectrome-
ter sample orifice remains at 0 kV. The electrostatic field between
the chip and the orifice drives the positive ions towards the mass
spectrometer. The flow rate is dependent on the chip diameter.
When not mentioned otherwise, all results were acquired with
the low flow rate chip (i.d. 2.5m) from Advion, providing a
flow rate of 20 nl/min. At this flow rate, 1l of sample pro-
vided stable static electrospray longer than 30 min, just like in
‘classical’ nanoelectrospray.
Every sample, consisting of 1l of solution was sprayed
twice and MS spectra were acquired either by full range acqui-
sition (full scan) or multiple overlapping segmented range
acquisition (selected ion monitoring, or SIM scans). For the BSA
sample, four segmented SIM mass ranges (300–500, 450–650,
600–800, 750–1350) were recorded. For the histone H3 sam-
ple, the four SIM segments were chosen as 300–550, 500–650,
600–750, and 700–900 m/z. MS/MS fragmentation was per-
formed by data-dependent selection of the five most intense
peaks in the segmented mass range. ‘Dynamic exclusion’ was
set to 150 s, longer than the acquisition time per two overlapping
segments.
2.4. Data analysis
The Mascot engine was used for mass spectrometry data
identification (Matrix Science, London, UK). BSA peaks were
searched in IPI Human v313 to which the BSA sequence had
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been added, using 5 ppm maximum mass deviation (MMD
[13]) for precursor ions, 0.5 Da MMD for fragment ions, car-
bamidomethylation (C) as fixed modification, and oxidation
(M), N-acetylation, deamidation (NQ), pyro-glutamate (N-term
QC) as variable modifications. Up to three missed cleavages
were allowed and every fully tryptic, unique peptide (‘bold red’
in the MASCOT report) without a second protein match was
accepted as a hit.
Histone H3 peaks were searched in a histone database
(276 non-redundant sequences, including different histone pro-
teins/variants, keratins and the proteases used), using 5 ppm
MMD for precursor ion, 0.5 Da MMD for ion-trap fragmen-
tation, and 0.01 Da mass tolerance for C-trap fragmentation
(minimum possible in Mascot), and seven variable modifica-
tions, including methionine oxidation, N-terminal acetylation,
mono-, and dimethylation of lysines and arginines and lysine
trimethylation and acetylation. Up to two missed cleavages were
allowed and peptides with a score higher than that corresponding
to a significance value of p = 0.05 were accepted.
3. Results and discussion
3.1. Automated nanoelectrospray coupled to the
LTQ-Orbitrap
‘Classical’ nanoelectrospray requires handling of fragile
pulled needles, which is both time consuming and a skill
demanding considerable dexterity. In contrast, the TriVersa
achieves the same low flow rates and thereby sensitivity using a
micro-machined chip that is operated completely automatically.
Here we describe operation of the automated nanoelectrospray
combined with a high accuracy mass spectrometer, the LTQ-
Orbitrap. The TriVersa automatically takes a tip, aspirates the
sample, and transfers it to the nozzle of the chip, located in front
of the mass spectrometer (Fig. 1). As can be seen in the figure,
the LTQ-Orbitrap contains a C-trap, which functions as a con-
tainer for ions transferred from the ion-trap and waiting to be
ejected into the high-resolution analyzer—the orbitrap. Impor-
tantly, the instrument allows any ion population isolated in the
ion-trap to be accumulated in the C-trap for final high-resolution
analysis in the orbitrap. This high-resolution scan in the orbitrap
takes 0.25–1 s, depending on the resolution chosen.
While the instrument is extremely sensitive, its duty cycle
is limited by the fact that the C-trap only accommodates 106
ions, which is often achieved with ion accumulation for just a
few milliseconds. Secondly, the dynamic range is also limited
by dominant ions (typically in the low to middle m/z range),
which can make up a large fraction of the total ion population.
We reasoned that the combination of nanoelectrospray and LTQ-
Orbitrap should allow us to ameliorate both problems. Instead
of acquiring a single full scan spectrum, we decided to acquire
a large number of spectra by filling up the C-trap to capacity
for each of a number of segmented mass ranges. This should
lead to a ‘normalized’ mass spectrum consisting of a ‘matrix’ of
individual spectra for several mass segments and averaged over
many scans. This ‘composite’ spectrum should have a much
larger dynamic range and peptide mass measurement accuracy
than a single full scan spectrum or averaged full scan spectra.
Furthermore, the long spray time allows directed and iterative
peptide fragmentation experiments. Peptides can be identified
by peptide mass fingerprinting (PMF), ion-trap fragmentation
with read out in the ion-trap or in the orbitrap, fragmentation in
the C-trap or any combination of these. We therefore sought to
devise efficient MS/MS schemes to characterize the maximum
number of peptide peaks.
3.2. Acquisition methods for the composite spectrum and
MS/MS acquisition
We found that a three step procedure, encompassing peptide
mapping, data-dependent sequencing and directed sequencing
of ‘missing’ peaks, was optimal for protein characterization
(Fig. 2). In the first step the full mass range is divided by SIM
scans into multiple overlapping segments (several hundred m/z
units wide), which were acquired in the orbitrap. The segmented
mass ranges, shown in Fig. 2A, were chosen so that the accu-
Fig. 1. Schematics of the TriVersa Nanomate coupled to the LTQ-Orbitrap. Samples were applied by coated tips to the nozzle of the electrospray chip in front of the
TriVersa instrument. The low flow rate chip (i.d. 2.5m) provided a stable flow rate of 20 nl/min, which is in the ‘true’ nanoelectrospray range.
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Fig. 2. Schematic description of the acquisition strategy as performed for protein characterization of tryptic digested BSA. (A) Selected ion monitoring (SIM) scans
of multiple mass segments were repeatedly analyzed in the orbitrap mass spectrometer and these multiple SIM acquisitions were combined in one ‘composite’
spectrum. (B) After each SIM scan, the five most intense ions were data-dependently selected for MS/MS fragmentation in either ion-trap or orbitrap. (C) Overview
of the complete protein characterization method, including the acquisition of the composite spectrum and the data-dependent SIM–MS2 mode. These two methods
are followed by a third strategy that aims to identify peptides that were not sequenced yet. In this directed SIM–MS2 mode all precursor masses that were not
fragmented so far are placed on an inclusion list. The entire experiment can be carried out with only 2l of very diluted sample solution.
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Table 1
BSA sequence as identified by the three-step method introduced in this paper. In total 2l of trypsin digested BSA sample was used for every concentration. One
microliter BSA was used to generate the composite SIM spectra and to carry out the data-dependent SIM–MS2 method. Both methods were performed three times
to assess their reproducibility. The second microliter was used specifically to characterize the peptides only identified by PMF but not sequenced yet. When all
identification methods were combined, a sequence coverage of 66% was reached even for 500 attomole/l
BSA concentrations Acquisition methods Sequence identified
per Individual Run (%) per Acquisition Method (%) Overall (%)






Inclusion list MS2 1.4 1.4






Inclusion list MS2 10.1 10.1






Inclusion list MS2 10.5 10.5
mulation time for every segment would be similar. Each mass
segment window was measured many times to gain sensitiv-
ity and precision. If several minutes are allocated to acquisition
of the composite survey spectrum, then each mass segment is
typically acquired more than 100 times.
First identification is based on peptide mass fingerprint
(PMF) analysis. Because of the high mass accuracy of the orbi-
trap, particularly when including an internal mass standard in
each spectrum (see below), dominant proteins in the sample are
readily identified at this stage. In the second step data-dependent
fragmentation is performed in each segmented range. Again SIM
survey scans are recorded for each m/z range but now they are
followed by ion-trap MS/MS spectra of the five most intense
peaks. For each m/z range, the SIM–MS2 cycle is repeated for a
time adapted to the number of MS/MS candidates (Fig. 2B). Pep-
tide identification is performed in the MS/MS ion search mode
and peaks identified by PMF are confirmed by the MS/MS ion
search. Since MS/MS spectra contain more information than the
peptide mass alone, many peaks that cannot be identified only
by the precursor mass are identified at this stage. This analysis
still leaves some peptide peaks unfragmented—mainly because
of their low signal, which may mean that they do not appear in
every scan. These peaks are then targeted by a so-called ‘inclu-
sion list’ in the third part of the measurement sequence. Fig. 2C
presents an overview of the three-step sequence.
Since the acquisition methods for composite full spectra and
SIM–MS2 take only 4 and 5 min, respectively, 1l of sample
sprays long enough to record both steps three times. A second
microliter is used for step three in which we specifically target
peaks not fragmented yet. Several microscans are applied for
both MS (SIM) and MS/MS acquisition to boost sensitivity and
data quality.
3.3. Subfemtomole sensitivity
Having established an efficient protocol for comprehensive
protein characterization, we wanted to assess its sensitivity on
a model protein. Using the strategy as described in Fig. 2C, we
obtained a sequence coverage of more than 80% for BSA. The
missing peptides were generally very short and some of them did
appear under different digestion conditions as ‘missed cleavage’
peptides. We found that the BSA concentration could be diluted
to 25 fmol/l without losing protein sequence coverage (data
not shown). Illustrating the excellent sensitivity of the set up
described in this paper, more than 60% of the BSA sequence
was still identified when the protein was diluted to 500 amol/l
(see Table 1). As shown in the table, the inclusion list SIM–MS2
method turned out to be particularly advantageous for lower
protein concentrations.
3.4. Extremely high mass precision in the composite full
spectra
The orbitrap detection is based on inherently very precise
frequency measurement and is, in our experience, much less
affected by space charge than a Fourier-transform ion cyclotron
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Fig. 3. Mass precision correlated to ion intensity. Plot of the intensity of different
ions extracted from the composite spectrum vs. their precision, from thousands
of scans depicted on a double logarithmic scale. Note that for most peaks we
achieve sub ppm mass precision.
resonance (FT-ICR) instrument. When combined with ‘lock
mass’ injection in every spectrum, the orbitrap is capable of
achieving low to sub-ppm mass accuracy [14]. We reasoned
that, by measuring each SIM mass range multiple times, the
mass values of peaks extracted from the composite full spectra
should become even more precise, since the standard deviation
of a population is inversely dependent on the square root of the
number of measurements. In our case, by repeated measurement
of the same spectrum for 100 times, the standard deviation of
the mass value should be decreased by a factor of 10. In Fig. 3,
the peak intensity is plotted versus peak precision on a double
logarithmic scale, and the data show that more intense ions yield
better precision within the same measuring time. As can be seen
in the figure, a large percentage of the peptides have a precision
well below 1 ppm, with some peptides even reaching 100 ppb or
less. Thus we conclude that the TriVersa–LTQ-Orbitrap combi-
nation is capable of extremely high mass accuracy, comparable
or superior to any other platform currently used in proteomics.
3.5. More than 6000-fold dynamic range in the composite
full spectra
Summing up multiple spectra filters out noise but boosts low
intense ions that cannot be distinguished from background peaks
in single spectra. We demonstrate further improvement of the
dynamic range by collecting segmented m/z ranges instead of
one full spectrum. Often a few, very intense ions comprise 90%
of the total ion number of a spectrum, whereas in the segmented
mass range regions with low intense signals are accumulated for
a longer time in order to reach the same specified injection target
value.
As depicted in Fig. 4A, the composite spectrum is much more
feature rich in the higher mass range compared to the spectrum
consisting of averaged full mass range spectra with the same total
acquisition time. Both the composite spectra and the summed-up
full spectra were acquired in the same experiment. As is apparent
from the figure, the S/N was much better (see arrows). With
the 25 fmol/l tryptic-digested BSA sample, we assigned BSA
peaks with a signal intensity difference of up to 6700 (Fig. 4B).
While the dynamic range of the orbitrap is specified at 104, this
value applies only to a simple two-component mixture. In our
experience, dynamic range in complex peptide mixture analysis
is around 103 in LC–MS experiments, so the composite spectra
exhibit a comparable or superior dynamic range for complex
samples to online experiments.
3.6. Sequence coverage comparable to LC–MS
We compared the sequence coverage obtained after 5 min of
SIM–MS2 acquisition with a conventional LC–MS run, both
times using 50 fmol of BSA and the same parameter settings on
the LTQ-Orbitrap. For this experiment, a higher flow rate chip
(i.d. 5m) was used for nanoelectrospray, resulting in a flow rate
of 200 nl/min. The LC–MS run took in total 53 min, of which the
actual gradient lasted for 28 min. Both methods were performed
twice. The sequence coverage obtained by these two methods
was very comparable, 83.7% for nanoelectrospray SIM–MS2
and 78.5% for LC–MS/MS. Detailed identification information
for each tryptic peptide in the BSA sequence is shown in Fig. 5.
Most of the peaks were identified by both methods, but some low
intensity peaks were only sequenced in LC–MS. This may be
due to the concentration effect of chromatography, where each
ion elutes in a very short time span in contrast to the long but
‘diluted’ duration in nanoelectrospray. On the other hand, there
were a few peptides that co-eluted with others and disappeared
before having a chance to be fragmented in LC–MS but those
were sequenced in the SIM–MS2 run.
3.7. Characterization of Histone H3 post-translational
modiﬁcations
Histones are the protein constituents of nucleosomes around
which DNA is wound in eukaryotic cells. Histone tails on the
nucleosome are subject to enzyme-mediated post-translational
modifications (PTMs) of selected amino acids, such as lysine
acetylation, lysine and arginine methylation, serine phosphory-
lation and attachment of ubiquitin [15,16]. These modifications,
singly or in combination, are thought to generate an epige-
netic code that specifies different patterns of gene expression
and silencing [17]. Characterization of post-translational mod-
ifications on bulk histones by mass spectrometric approaches
has proven to be very successful as recently reviewed by Hunt
and co-workers [18]. Here we investigate the suitability of the
nanoelectrospray–orbitrap combination to characterize modifi-
cations on histone H3 purified from human HeLa cells, separated
from other histone molecules by RP-chromatography and in-
solution digested with Arg-C protease. In order to distinguish
between several modifications present on such molecules, many
of them only differing in single methyl or acetyl groups, we
also employed high resolution read out of MS/MS spectra in the
orbitrap. Furthermore, fragmentation was performed by higher
energy injection into the C-trap [19], which leads to triple-
quadrupole like behavior and preservation of the full mass range
in the MS/MS spectra. Fragmentation spectra were acquired at a
resolution of 30,000 and the mass accuracy was in the low ppm
range for these fragmentation spectra.
More than 500 peaks were extracted from the composite full
spectra. Spectra recorded in SIM–MS2 mode were searched in
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Fig. 4. Advantages of composite spectra. (A) In the composite spectrum ions of low intensity were boosted in comparison to full spectra summed-up for the same
time span. 500 attomole/l BSA sample was sprayed, and the composite spectra and the summed-up full spectra were acquired directly after one another. Whereas
for intense ions there is no large visible difference, the S/N ratio for low intense ions increases dramatically. (B) A dynamic range of over 6000-fold was obtained in
the composite spectrum. 25 fmol/l BSA resulted in a composite spectrum, in which the most intense peptide with m/z of 487.73 (2+, DLGEEHFK) had an intensity
of 8.85E4, while the peptide at m/z 962.12 (3+, LVTDLTKVHKECCHGDLLECADDR) was observed with an intensity of 13.2 (inset), resulting in a dynamic range
of 6700.
a histone database and 46% of the sequence of histone H3 was
identified (based on peptides with a score higher than p < 0.05).
The heavily modified N-terminal sequence was completely cov-
ered and seven differently modified peptides were detected
(Table 2). In six of them the modified residues were unambigu-
ously determined. In particular, the high mass accuracy of the
orbitrap allowed easy distinction between trimethylation and
acetylation, both of which are important histone modifications
that have the same nominal mass. In the seventh peptide, the
trimethylated and acetylated peptide KSTGGKAPR, the modi-
fied sites could not unambiguously be assigned to the sequence
since the fragmentation was performed in the LTQ and the
mass difference between these modifications (0.0364 Da) is far
less than what the LTQ can distinguish. Therefore, a second
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Fig. 5. Comparison of the BSA sequence coverage obtained in SIM–MS2 vs. LC–MS/MS mode. In both experiments 50 fmol of BSA solution were used and both
measurements were performed with the same instrument settings. Peptides in blue are identified in both methods, red peptides only in SIM–MS2 and green peptides
only in LC–MS mode. Black peptides were not identified.
Table 2
Histone H3 modifications (combinations) identified by the SIM–MS2 method
Modified amino acids Sequence
K4 monomethylation TKQTAR
K9 dimethylation + K14 acetylation KSTGGKAPR
K9 trimethylation + K14 acetylation
K23 acetylation KQLATKAAR
K18 acetylation + K23 acetylation
K79 monomethylation EIAQDFKTDLR
K79 dimethylation
microliter of the sample was sprayed and C-trap fragmentation
was performed combined with recording of the MS/MS spec-
tra in the orbitrap. With the resulting high mass accuracy, both
types of modifications were confirmed and trimethylation was
assigned to K9 and acetylation to K14.
The reported seven modified peptides are relatively abundant
in the bulk preparation histone sample, and have already been
reported by either top-down [20] or LC-based bottom-up [18]
mass spectrometric method. Our approach provides an alterna-
tive way to characterize histone by bottom up mass spectrometric
analysis without online LC separation. Preliminary work further-
more indicates that modifications on short peptides that escape
detection by LC–MS/MS can be detected by automated nano-
electrospray (data not shown).
3.8. Relative quantitation by deconvoluted peak intensity
As mentioned above, quantification of peptides and proteins
is becoming more and more important. An advantage of the
acquisition of a large number of spectra is the increasing preci-
sion, not only of the mass value but also of the intensity ratio
between ions. This will be illustrated with the ratio between
two different BSA peptides as well as with the ratio between a
methylated and non-methylated histone peptide.
Fig. 6 illustrates the relative quantitation of BSA peptides.
Panel A shows the m/z segment 300–500. Fig. 6B reveals that the
ratio of the relative intensities of the peptides with m/z 395.239
(2+) and 379.715 (2+) varied per spectrum between 1.7 and 3.5.
However, with increasing number of accumulated spectra quan-
titation becomes more and more precise. As shown in Fig. 6C,
the 99% confidence interval for quantitation decreases from 13%
after accumulating 10 scans to 0.9% after accumulation of 1500
scans (15 min acquisition).
In the case of histone H3 we investigated quantitation of the
normal peptide against a slightly modified form. This is possible
in nanoelectrospray since both peptides are present in the same
scan. In order to avoid inaccuracy due to transmission ‘edge
effects’ in the SIM windows, we chose to quantify based on
the full spectrum. The relative quantitation values for identified
histone H3 peptide pairs are listed in Table 3. The amounts of
several methylated peptides were about 10-fold less than those of
the unmodified peptides. Note that this value gives a general idea
Table 3
Quantitation values of identified peptide pairs with the same sequence but different modifications
Identified peptide pairs Quantitation value with 99% confidence interval
TKQTAR/TK(methyl)QTARK 11.791 ± 0.916
K(dimethyl)STGGK(acetyl)APR/K(trimethyl)STGGK(acetyl)APR 9.849 ± 0.826
KQLATK(acetyl)AAR/KQLATK(diacetyl)AAR 14.651 ± 1.307
EIAQDFKTDLR/EIAQDFK(methyl)TDLR/ 11.391 ± 0.868
EIAQDFK(methyl)TDLR/EIAQDFK(dimethyl)TDLR 8.206 ± 0.990
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Fig. 6. Highly accurate relative quantitation by the ratio of ion intensities within
one segmented spectrum. Segmented SIM scans from m/z 300 to 500 were
acquired for 15 min with 25 fmol/l tryptic BSA. (A) A single SIM scan includ-
ing the ions with m/z 395.239 (2+) and 379.715 (2+) of which the ratios of
intensities were quantified. Per single scan the ratio varies from 1.5 to 3.5
(B). With an increasing number of accumulated spectra, the precision of the
quantitation ratio increases, as shown in (C).
of the absolute stoichiometry of this methylation site but that it
needs to be corrected for the different ionization efficiencies of
the modified versus the unmodified peptides [21].
4. Conclusions and perspectives
In this paper, we have endeavored to revive nanoelectrospray,
an ‘old’ protein mapping method using no chromatographic pep-
tide separation, as an alternative to MALDI peptide mapping.
Using the advantages of a stable spray in combination with the
LTQ-Orbitrap mass spectrometer, we have introduced the con-
cept of ‘composite spectra’, which are spectra composed of a
high number of segmented SIM scans. These composite spec-
tra allow very high sensitivity, accuracy and dynamic range due
to optimized C-trap fill times for each mass segment. In the
automated format of the TriVersa Nanomate, nanoelectrospray
measurements are robust, user-friendly and easily amenable for
different protein samples while using very low amounts of spray-
ing solution. Since the instrument can readily switch between
MS and MS/MS, and between fragmentation in the linear ion-
trap and the C-trap, it offers a large number of complementary
methods and is very flexible and user-friendly.
The LTQ-Orbitrap mass spectrometer is a dual instrument
with two independent detection systems (orbitrap and LTQ),
which can be operated simultaneously, thus the ideal combi-
nation would be to fragment high intense ions in the orbitrap
while simultaneously performing ion-trap fragmentation of low
intensity ions. This would increase the duty cycle and analysis
speed. However, this requires direct access to the LTQ-Orbitrap
acquisition software, which we are currently lacking. At the
other extreme of acquisition sophistication is the so-called ‘ion-
mapping’ technique. In this method, the whole mass range is
scanned step by step by SIM-scans of for example 6 Da win-
dows with and without applying collision energy to fragment the
ions in this small window. Especially for complex mixtures this
method could in principle be very valuable in a nanoelectrospray
setup since the dynamic range is expected to be further increased
by these small segments. However, when we tried this method
we found that it allocates too much time to ‘empty’ regions and
is thus overall less efficient than the method described here.
In order to further improve protein characterization, we plan
to access to the LTQ-Orbitrap acquisition software directly
and perform genuine ‘real time’ data acquisition. Fragmen-
tation (MS2 or MS3) will focus on the peaks recognized in
the survey scan but not identified in the search with expected
variable modifications. This will allow identification of new
peptide sequences, variant alleles or unexpected modifications.
Of course, digestion with multiple enzymes is also an obvious
next step for even more for more in-depth characterization of
modified peptides.
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Detergent-Based but Gel-Free Method Allows Identification of
Several Hundred Membrane Proteins in Single LC-MS Runs
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Detergents are indispensable solubilizing agents in the purification and analysis of membrane proteins.
For mass spectrometric identification of proteins, it is essential that detergents are removed prior to
analysis, necessitating an in-gel digestion step. Here, we report a procedure that allows use of detergents
and in-solution digestion of proteins. Crude membrane preparations frommouse brain were solubilized
with Triton X-100, CHAPS, or SDS, and the detergents were depleted from the membrane proteins
using a desalting column equilibrated with 8 M urea. Following digestion with endoproteinase Lys-C,
the resulting peptides were analyzed by LC-MS/MS on Linear ion trap-Orbitrap instrument. Applying
stringent identification criteria, in single-LC-MS-runs, 1059( 108 proteins, including 797( 43 membrane
proteins, were mapped from mouse brain. The identified proteins represented a broad spectrum of
neurotransmitter receptors and other ion channels. The general applicability of the method is
demonstrated by profiling of membrane proteins from four other mouse organs. Single-run analyses
of eye, liver, spleen, and skeletal muscle allowed identification of 522 ( 9, 610 ( 7, 777 ( 8, and 307
( 7 membrane proteins. Our results demonstrate that membrane proteins can be analyzed as efficiently
as soluble proteins.
Keywords: Membrane proteomics • integral membrane proteins • detergent removal • brain • liver •
eye • spleen • muscle • LTQ-Orbitrap
Introduction
The use of detergents in biochemical research ranges from
standard procedures, such as SDS-PAGE or pull-down experi-
ments, to complex, specialized applications, such as extraction
of integral membrane receptors consisting of multiple subunits.
In the field of membrane biochemistry, detergents are indis-
pensable tools for solubilization and fractionation of membrane
proteins. However, detergents, even in small concentrations,
dominate mass spectra and preclude peptide or protein
analysis. Thus, in mass spectrometry (MS)-based proteomics,
detergents have to be efficiently and thoroughly removed from
proteins or peptides prior to analysis, but this is not an easy
task. Different methods have been described for separation of
proteins from detergents including gel filtration, ion-exchange
and hydrophobic adsorption chromatography, density gradient
centrifugation, dialysis, ultra filtration, phase partition, and
precipitation (for a review see ref 1). However, they have not
become popular in mass spectrometry because of their inability
to completely remove the detergents.2 Moreover, these meth-
ods can lead to substantial sample losses as they have been
designed to deal with relatively high protein amounts; thus,
their applicability to proteomics is limited.
To circumvent the difficulties with removal of detergents,
alternative approaches avoiding the use of detergents have been
proposed. For example, 60% methanol3,4 was used for the
solubilization of membranes and the extracted proteins were
digested with trypsin. In another approach, membranes
were solubilized with 90% formic acid and the proteins were
chemically cleaved with cyanogen bromide.5 In addition,
digestion of membrane proteins directly in a suspension of
fractions enriched in membranes has been described. Wu et
al. used proteinase K at high pH to digest protein chains
protruding from the membrane bilayer.6 Using a related
concept, we analyzed mouse brain membrane proteins by
digesting purified plasma membranes in 4 M urea with en-
doproteinase Lys-C.7 We further applied this ‘solid-phase
digestion’ strategy in protein profiling8 and comparative,
semiquantitative mapping of plasma membrane proteins be-
tween distinct regions of mouse brain.9,10
Despite these developments, detergents are preferred due
to their strength in membrane solubilization and are widely
used in sample preparation for subsequent proteomic analysis.
Unfortunately, so far the only method to efficiently remove
detergents once they were introduced involved in-gel digestion
after SDS-PAGE or, alternatively, incorporation of detergent-
containing protein lysates into a polyacrylamide matrix without
electrophoresis.11
In this work, we present a novel procedure for detergent
removal and digestion of membrane proteins, and compare it
with an in-gel protein immobilization and digestion procedure.
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We show that membrane proteins solubilized with Triton X-100,
CHAPS, or SDS can be efficiently separated from the detergents
by ‘desalting’ on a column equilibrated with 8 M urea. In this
protocol, the proteins are digested with endoproteinase Lys-C
and the resulting peptides are bound to a C18 membrane and
analyzed by LC-MS/MS. Our method results in an almost 2-fold
increased protein identification in comparison to the in-gel
based approach. We demonstrate that our procedure is useful
for profiling of membrane proteins from various tissues includ-
ing mouse brain, liver, spleen, eye, and muscle tissues.
Materials and Methods
Membrane Preparation and Protein Solubilization. Frozen
mouse brain, liver, spleen, leg muscle and eye were purchased
from Pel-freez Biologicals, Rogers, AR. Membrane preparation
was carried out as described previously.8 Briefly, 20 mg of tissue
was homogenized in 1 mL of high salt buffer (2 M NaCl, 10
mM HEPES-NaOH, pH 7.4, 1 mM EDTA) using IKA Ultra
Turbax blender at maximum speed for 20 s. The suspension
was centrifuged at 16 000g, at 4 °C for 15 min. The resulting
pellet was re-extracted twice with carbonate buffer (0.1 M
Na2CO3, pH 11.3, 1 mM EDTA) as above. After incubation for
30 min, the pellet was washed with urea buffer (4 M urea, 100
mM NaCl, 10 mM HEPES/NaOH, pH 7.4, and 1 mM EDTA).
Following urea wash, the pellet was solubilized in 50 µL of 100
mM sodium phosphate buffer, pH 7.0, containing either 2%
(w/v) SDS, 0.5% (v/v) Triton X-100, or 3.5% (w/v) CHAPS.
Removal of Detergents and Protein Digestion with Endopro-
teinase Lys-C. Detergents were removed on a HiTrap desalting
column (5 mL, Amersham Biosciences, Uppsala, Sweden). The
column was equilibrated with 8 M urea, 25 mM Tris-HCl, pH
8.0. The proteins were digested with 0.5 µg of endoproteinase
Lys-C fromWako (Richmond, VA) at 25 °C overnight. Digestion
was terminated by addition of 1% (v/v) trifluoroacetic acid. The
digested peptide mixture was purified and stored in C18
StageTips as described.12 Usually, 5% of the digestion mixture
was loaded on a StageTip containing two membrane plugs.
In-Gel Digestion. Detergent solubilized membrane prepara-
tions were mixed with sample buffer, loaded on NuPAGE 4-12%
Bis-Tris gel (Invitrogen, Carlsbad, CA), and stacked in the gel by
electrophoresis at 50 V for 15 min. The gel was stained with
Coomassie blue staining kit (Invitrogen), and entire lanes (usually
0.5 cm in length) were excised and in-gel digested as described.13,14
Mass Spectrometric Analysis. Protein digests were analyzed
by online capillary LC-MS/MS. The LC-MS/MS setup was
similar to that described before.15 Briefly, samples were sepa-
rated on an in-house made 15 cm reversed phase capillary
emitter column (inner diameter 75 µm, 3 µmReproSil-Pur C18-
AQ media (Dr. Maisch GmbH, Ammerbuch-Entringen, Ger-
many)) using 120 min gradients and an Agilent 1100 nanoflow
system (Agilent Technologies, Palo Alto, CA) or 90 min gradients
using a Proxeon EASY-nLC (Proxeon Biosystems, Odense,
Denmark). The LC setup was connected to an LTQ-Orbitrap
(Thermo Fisher, Bremen, Germany) equipped with a nano-
electrospray ion source (Proxeon Biosystems). The mass spec-
trometers were operated in data-dependent mode. Survey MS
scans were acquired in the orbitrap with the resolution set to
a value of 60 000. Up to 5 most intense ions per scan were
fragmented and analyzed in the linear ion trap. For accurate
mass measurements, the lock-mass option was employed.16
Peak List Generation, Database Searching and Validation.
The raw files were processed with MaxQuant, an in-house
developed software suite (version 1.0.6.3).17,18 The peak list files
were searched against decoy IPI-mouse database version 3.24
containing both forward and reversed protein sequences, by
the MASCOT search engine.19 The initial parent and fragment
ion maximum mass deviation20 were set to 7 ppm and 0.5 Th,
respectively. The search included variable modifications of
oxidation of methionine and protein N-terminal acetylation.
Peptides with at least seven amino acids were considered for
identification and proteins with two or more peptides (at least
one of them unique to the protein sequence) were considered
valid hits. The false discovery rate for both the peptides and
proteins were set a threshold value of 0.01. All proteins
identified in this study are listed in Supplementary Table 1 in
Supporting Information.
Bioinformatics Analysis. Gene ontology analysis of the
identified proteins were performed using the Protein Center
platform (Proxeon Biosystems, Odense, Denmark) primarily for
cellular component analysis and membrane and transmem-
brane domain annotations.
Results and Discussion
Previously, we have described a detergent-free method for
proteomic analysis of membrane proteins.7 In that method,
membranes are directly digested with endoproteinase Lys-C
and the released peptides are analyzed using one-7,9 or two-
dimensional LC-MS/MS.8,10,21 Even though this method is a
powerful tool for mapping of membrane proteins, it has some
limitations. Proteolytic digestion is performed on only partially
denatured proteins (4 M urea); therefore, the yield of peptides
is restricted by accessibility of the cleavage sites to proteases.
Moreover, this method cannot be combined with chromatog-
raphy techniques for separation of membrane proteins before
digestion. We wished to develop a method that can be coupled
with chromatographic separation like size-exclusion chroma-
tography for in-depth analysis of membrane proteome of tissue
samples. The use of detergents for extraction of membrane
proteins would circumvent the above-mentioned limitations
and, in addition, offer the option of stepwise extraction of
membrane proteins which potentially can be used for selective
protein solubilization and fractionation of membrane pro-
teins.22-24
Removal of Detergents. The major goal of this work was to
establish a simple, effective, and robust method for removal
of detergents from solubilized membranes, such that mass
spectrometric analysis would not be affected. For this purpose,
crude membrane preparations from mouse brain were ex-
tracted with three different detergents including SDS, Triton
X-100, and CHAPS, which are representative of anionic, non-
ionic, and zwitterionic detergents, respectively. The detergents
were used in relatively high concentrations, exceeding their
critical micellar concentration (CMC) values several-fold. The
membrane preparations were solubilized with 3.5% (w/v)
CHAPS, 2% (w/v) SDS, and 0.5% (v/v) Triton X-100. Since size
exclusion chromatography has been reported to be highly
effective in detergent removal,25 we considered the use of gel
filtration in our experiments. To separate detergents from
proteins and to dissociate micelles, while keeping membrane
proteins in solution, we employed the strongly chaotropic
reagent urea at 8 M concentration. In the presence of 8 M urea,
micelles dissociate while membrane proteins stay in solution.
Importantly, the detergent migrates into the gel filtration
matrix, while proteins elute in the void volume. Thus, when
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the gel filtration columns equilibrated with 8 M urea were used,
it was possible to efficiently separate proteins from the
detergent.
After digestion with Lys-C, and removal of urea on StageTips,
the peptides were analyzed by LC-MS/MS. We did not observe
any detergent contamination in any of our experiments,
demonstrating the efficiency of the depletion. Results were
similar for all three tested detergents. Overall, 56.2 ( 2.5% of
the identified proteins from the brain membrane preparation
contained predicted transmembrane domains. This is an even
higher proportion than in our previously reported method for
profiling of membrane proteomes where the proteins were
digested directly from membranes in a suspension.8 In that
method, about 40% of the identified proteins contained
predicted transmembrane segments.8-10 Note that not all
membrane proteins contain transmembrane domains; there-
fore, the proportion of membrane proteins in our preparations
is even higher (nearly 80%; see below).
To demonstrate the efficiency of the protein digestion in
urea, we compared it to the in-gel digestion procedure. Five
samples for each procedure were prepared using aliquots from
the same membrane preparation. We found that the number
of proteins identified by the in-solution method was more than
twice that identified by the in-gel method (Figure 1A). Fur-
thermore, the sequence coverage of identified proteins was a
third higher in the new method (Figure 1B). The total number
of membrane proteins identified in the 10 runs was 956. Of
those, 537 and 40 proteins were exclusively identified in the
in-solution and the in-gel method, respectively (Figure 1C). The
proteins that were identified only by the in-solution method
do not show any obvious physio-chemical difference compared
to proteins identified by in-gel method. These proteins were
likely not identified by the in-gel method due to a combination
of less efficient peptide extraction by the in-gel method and
stochastic ‘picking’ of peptide peaks for sequencing. However,
we observed that we were able to recover more large proteins
by the in-solution method. Using our method, we identified
27 proteins consisting of more than 1500 residues, whereas only
one protein of this size was found using the in-gel approach.
Thus, the results achieved using the new method encompass,
rather than complement, the in-gel method.
Comparison to Published Membrane Proteome Ana-
lyses. The membrane proteome has been one of the most
difficult challenges for 2D gel electrophoresis and usually very
few or no transmembrane proteins are reported with that
technology. MS-based proteomics has been more successful,
but so far, researchers had to reduce protein complexity by
applying different protein and peptide fractionation strategies
that can facilitate the identification of less abundant proteins.
However, multidimensional separation also generates large
numbers of fractions that have to be analyzed individually
which requires extensive measurement time. For rapid screen-
ing of tissue specimens such as clinical biopsy material, high-
throughput methods are required. As described above, the
combination of the previously developed method for extraction
of membranes8 with the here described detergent-based solu-
bilization of membrane proteins resulted in identification of
530 proteins with predicted transmembrane domains from a
mouse brain sample. To assess the relative usefulness of our
method, we compared our results from single MS runs to other
membrane proteome analyses in the recent literature, which
employed extensive fractionation. In terms of identification of
membrane proteins and the analysis time required, our method
shows significant advantages. For example, a recently reported
3-D-strategy for analysis of membrane proteins allowed iden-
tification of only 125 proteins membrane proteins in mouse
brain.26 Other approaches for studying membrane proteins
from various sources including Corynebacterium glutamicum
and human platelet membranes have been carried out. Fischer
et al., characterized the membrane proteome of two strains of
C. glutamicum and reported 326 integral membrane proteins
involving multiple fractionation steps and extensive mass
spectrometric measuring time.27 Moebius et al. in their platelets
study identified less than 300 proteins with approximately 30%
membrane proteins.28 More recently, improved protocols for
analysis of enriched membrane proteins have been published.
Analysis of membrane fraction from HeLa cells using a phase
transfer surfactant-aided digestion procedure resulted in iden-
tification of 764 membrane proteins (53% of total identified
proteins) in 12 cumulative LC-MS/MS runs.29 In another study,
methanol was used to improve the efficiency of tryptic diges-
tion which allowed identification of a total of 690 integral
membrane proteins in 72 LC-MS/MS runs.30
Identification of Brain-Specific Proteins. A single run on
the LTQ-Orbitrap instrument identified approximately 800
proteins. More than 70% of these were membrane proteins and
59% had predicted transmembrane domains (Figure 2C). The
combination of our sample preparation procedure with high
Figure 1. Comparison of membrane protein identification efficiency (A) and sequence coverage (B) using in-solution and in-gel methods.
Brain membranes were extracted with 2% SDS. Five aliquots from the same extract were digested either in solution or in-gel. C, Venn
diagram comparing the numbers of identifications achieved with both digestion methods.
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resolution MS analysis yielded a large number of brain-specific
proteins. These include neurotransmitter receptors such as
glutamate and GABA receptors and also ion channels such as
sodium and potassium channel proteins (Supplementary Table
2 in Supporting Information). The identified glutamate recep-
tors represent ionotropic-AMPA, NMDA, metabotropic, and
GluRdelta-2 receptors. Four subunits of GABAA receptor and
two subunits of GABAB receptors were identified. A complete
set of subunits of the voltage-dependent calcium channel was
also mapped, including the channel subunit Cacna1a (and its
isoform Cacna1e) as well the auxiliary subunits alpha2/delta,
beta, and gamma. The channel subunit is a 281 kDa polypep-
tide with 23 predicted transmembrane helices. Similar in size
and number of transmembrane domains is the identified
sodium channel protein Scn1a (230 kDa, 23 transmembrane
segments). Identification of such large proteins is an important
advantage of our method.
Application of the Method to Other Tissues. Having dem-
onstrated the efficiency of our method with mouse brain tissue,
we wanted to show its applicability to a wide range of tissues.
We selected liver, spleen, eye, and skeletal muscle which
represent widely different tissue types. Each sample was
analyzed in triplicate (Figure 3). We observed that the number
of membrane proteins identified was dependent on the prop-
erties of the organs and ranged from 797 ( 43 in the brain to
307 ( 7 in leg muscle (Figure 2A). With respect to the total
number of proteins identified, the percentage membrane
proteins ranged from 66% in eye to 78% in brain (Figure 2C).
The comparatively low number of proteins identified in leg
muscle was due to the highly abundant titin, which has a
molecular weight of several MDa and takes up most of the
sequencing time in the mass spectrometer. Only small differ-
ences in the number of identifications were observed between
each of the three runs, and therefore, the cumulative number
of identified proteins for each tissue was only slightly higher
compared to a single run which emphasizes the reproducibility
of our method (Figure 2A,B).
Analysis of subcellular location of identified membrane
proteins using Gene Ontology revealed distinct origin of
membranes, which may reflect abundance of different or-
ganelles in the analyzed tissues (Figure 3). Mitochondrial
membranes appear to be the most abundant in all analyzed
samples ranging from 24% in brain to 44% in skeletal muscle.
The high content of mitochondrial proteins in leg muscle
reflects the fact that muscles are extremely rich in mitochondria
for ATP production. The percentage of proteins annotated as
extracellular or cell surface, which are mainly plasma mem-
brane proteins, was very similar between the tissues and at
17-22%. Liver and spleen membranes contained the highest
percentage of proteins annotated as endoplasmatic reticulum
(Figure 3C,B). The abundance of endoplasmatic reticulum in
liver is related to the high level of protein synthesis including
major plasma proteins such as albumin. Compared to other
tissues, brain and eye have the highest content of cytoplasmic
vesicle proteins (Figure 3A,E), which reflects the importance
of vesicular transport of neurotransmitters in nerve tissue.
Figure 2. Identification of proteins from membrane preparations of mouse brain, spleen, liver, skeletal muscle, and eye. (A) single
experiment; (B) cumulative result from 3 independent experiments; (C) content of membrane annotated proteins and proteins with
predictable transmembrane segments. Dark bars, total protein number; light bars, membrane annotated proteins, striped bars, proteins
with predictable transmembrane segments.
Figure 3. Subcellular localization of membrane proteins from mouse brain (A), spleen (B), liver (C), skeletal muscle (D), and eye (E).
GOL, Golgi apparatus; PM, plasma membrane; VES, cytoplasmic vesicles; ER, endoplasmatic reticulum;MIT, mitochondria, N, nucleus.
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In most cases, purification of organelles is not an easy task,
in particular, when only minute amounts of frozen tissue are
available. Our results demonstrate that relatively high numbers
of membrane proteins belonging to various organelles can be
profiled without extensive fractionation, simplifying protein
quantitation.
Conclusions
Detergents are powerful agents for solubilization of biological
membranes and allow separation of membrane proteins using
chromatographic methods such as size exclusion and ion-
exchange chromatography. Development of methods for mass
spectrometry-based proteomics of biological membranes is
currently a subject of many investigations. As detergents are
almost indispensable reagents in membrane biochemistry, the
majority of relevant studies involve in-gel digestion to remove
detergent prior to mass spectrometric analysis. In this work
we introduced a simple and highly reproducible method for
membrane proteomics that allows use of detergents. Moreover,
we showed that the gel-free analysis of membrane proteins
yields more than twice the number of protein identifications
compared to in-gel digestion. Since our method offers a fast
and reproducible means for analysis of membrane proteins,
we believe that it may be suitable for high-throughput
applications.
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5 Analysis of post translational modification of linker 
histone H1 variants from human breast cancer sample 
using the peptide mapping method 
 
5.1 Publication: Mapping of Lysine Monomethylation of Linker Histones in 
Human Breast Cancer  
 
This manuscript presents the result from the project of the post translational modification 
analysis of linker histone H1 variants from human breast cancer sample. At the time of 
writing this thesis, it is being re-submitted to the journal of Molecular and Cellular 
Proteomics. The following pages contain the submitted version of the manuscript. 
 
 



































Linker histones H1 are key modulators of  chromatin  structure. Tightness of  their 
binding  to DNA  is  regulated by  posttranslational modifications.  In  this  study we 
have  analyzed  posttranslational  modifications  of  five  major  variants  of  H1  in 
human  tissue  ‐ H1.0, H1.2, H1.3, H1.4, and H1.5. To  improve sequence coverage, 
tryptic peptides of H1 were separated by HPLC and  the  individual  fractions were 
analyzed using a peptide on‐chip  implementation of nanoelectrospray  (TriVersa), 
coupled  to a  linear  ion  trap‐Orbitrap hybrid  instrument. For quantitative analysis 
of  lysine  methylation,  ionization  efficiencies  of  methylated  and  non‐methylated 
peptides  were  determined  using  synthetic  peptides.  Our  analysis  revealed  that 
monomethylation of  lysine residues alongside with phosphorylation of serine and 
threonine residues  is the major modification of H1  in tissue.   We found that most 
prominent methylation sites are in the N‐terminal tail and the globular domain of 
H1.  In the C‐ terminal domains we  identified only few  less abundant methylation 
sites. Quantitative analysis revealed that up to 25% of H1.4 is methylated at K‐26 in 
human tissues. Another prominent methylation site was mapped to K‐27  in H1.5, 
which  resembles K‐26 site  in H1.4.  In H1.0  five  less abundant  (<1% of H1.0) sites 
were  identified. Analysis of patient matched pairs of cancer and adjacent normal 
breast  demonstrated  high  variation  between  individuals.  Our  study  revealed 
differences in methylation of linker histones between normal breast and its cancer.   











between  the modifications and  the epigenetic regulation of chromatin  is known as 







spread  in all cells  (10),  the  levels of other  three are more variable. H1.1 variant  is 
considered  a  specific  variant  for  thymus,  testis,  and  spleen,  lymphocytic  and 
neuronal  cells.  H1.0  variant  is  abundant  in  terminally  differentiated  cells  but 
significant  levels of  this variant were  identified  in cultured cancer cells  (10,11) and 
detected by  immunochemistry  in breast carcinoma  (12). Expression of H1.X variant 
gene has been observed across  the majority of  tissues, but so  far,  the protein was 
identified  solely  in  cultured  cells.  Functional  specificity  of  the  individual  variants 
remains obscure (13).  
 
For  a  long  time,  in  contrast  to  core  histones,  H1 was  considered  as  to  be  solely 
modified by S/T kinases, mainly by CDK1 (14,15). Recently, monomethylation of K‐26 
in  human  H1.4  variant  (16)  and  lysine  acetylation  for  the  Tetrahymena  H1 were 
reported  (17). Our  recent  studies  on modifications  of H1  in  two  cells  lines  and  9 
mouse tissues revealed a greater array of posttranslational modifications. In addition 
to previously described phosphorylation, we  found  that  linker histones are mono‐, 
and  dimethylated,  acetylated,  formylated,  and  ubiquitinated  (10),  thus  they  are 
sharing  some  similarity  with  core  histones  in  respect  to  posttranslational 
modifications. Our study also revealed  that  linker histones  from  tissues carry more 









not  necessarily  reflect  the  situation  in  vivo.  In  this  work,  we  have  analyzed  and 
compared posttranslational modifications of  the histone H1  variants  isolated  from 
breast  carcinoma  and  normal  breast.    Our  analysis  was  performed  on 
chromatographically separated peptides using a peptide on‐chip  implementation of 
nanoelectrospray (TriVersa), coupled to a linear ion trap‐Orbitrap hybrid instrument 
(18).    For  quantitative  analysis  of  lysine  methylation,  ionization  efficiencies  of 
monomethylated  and  non‐methylated  peptides were  determined. We  show  that, 







the adjacent normal  tissue were  retrieved during  surgery. Analysis of  the  samples 
followed an  informed consent approved by the  local ethics committee. The protein 
extraction  procedure was  carried  out  as  described  previously  (10).  Briefly,  frozen 
tissue was  homogenized with  3  vol.  (m/v)  of  5 %  (v/v)  HClO4  using  an  IKA Ultra 
Turbax blender and  the homogenate was centrifuged at 15,000 × g  for 5 min. The 
supernatants  were  precipitated  by  addition  of  100%  (v/v)  CCl3COOH  to  a  final 
concentration  of  33%  (v/v).  After  30  min  on  ice  the  precipitate  collected  by 
centrifugation at 15,000 × g for 10 min. 
 
Histone  H1  purification,  digestion  and  peptide  fractionation  –  The  protein  pellets 
were  dissolved  in  water  and  chromatographed  on  C18  reverse  phase  column  as 
described previously (10,19). Fractions containing histone H1 were collected and the 
proteins  vacuum  dried.    Dried  protein  pellets  were  reconstituted  in  100  mM 
ammonium bicarbonate and digested with trypsin overnight at 37 °C. The resulting 



















was  performed  as  described  previously  (18). Briefly,  peptides were  analyzed  by  a 
chip  implementation of nanoelectrospray  (TriVersa Nanomate, Advion Biosciences, 








in  two  overlapping  segmented mass  range  (75‐600,  550‐1150,  SIM  scans) with  a 
resolution of 60000  in  the Orbitrap, and up  to 3 most  intense  ions per  scan were 
fragment  in the C‐trap and acquired  in the Orbitrap with a resolution of 15000. All 




MS2 was  set  roughly  to  1:1.  Target  values were  1,000,000  for  full  scan,  300,000–









Protein and posttranslational modifications  identification – Combined peak  lists  for 
histone samples were extracted by MaxQuant software (21). The data were searched 
against  a  histone  database  (298  non‐redundant  sequences,  including  different 
histone  proteins/variants,  High  mobility  group  protein  variants,  keratins  and  the 
proteases used) with  the  aid of  the MASCOT  (Matrix  Science,  London, UK)  search 
engine  (22),  using  10  ppm  MMD  for  precursor  ion,  0.4  Da  MMD  for  ion‐trap 
fragmentation,  and  0.01 Da mass  tolerance  for C‐trap  fragmentation. Up  to  three 
missed  cleavages  were  allowed.    No  fixed  modification  was  applied,  and  eight 




modified peptides with a  length  longer than 6 amino acids,    IT MS/MS was enough 
for the ones with at least 3 amino acids conservatively identified  and a score higher 
than  that  corresponding  to  a  significance  value  of  p  =  0.05;  2)  for  non‐modified 
peptides  with  a  length  equal  to  5  or  6  amino  acids,  only  whole  sequence 
identification from FT MS/MS were accepted; 3) for methylation, accurate precursor 
ion m/z ( 14.01 delta mass add‐up for one methyl group) and elution time (within ±1 
elution  faction)  compared  to  the  non‐metylated  corresponding  peptide  sequence 








eluted  either  in  the  same  or  different  fractions with  the  same  peptide  sequence 






without modifications,  leading  to  different  relative  quantitation  strategies  for  the 
two situations. For the peptide pairs eluted in the same fraction, deconvoluted peak 
intensity  from  the  2‐min‐full‐range‐summed‐up  spectrum  was  used  for  relative 
quantitation, the same as described previously (18). And for the peptide pairs eluted 
in  different  fractions,  the  total  ion  current  of  all  peaks  of  the  same  peptide with 
different  charge  states  in  different  fractions  was  used  for  relative  quantitation. 
Relative quantitation  ratio of methylation was calculated  independently  in peptide 
pairs with the same  tryptic cleavage  (details were  listed  in supplementary table 2), 
and  the average  ratio of one particular modified  site  in different  cleaved peptides 
was  considered  as  the  relative  ratio  for  the  sample.  The  occupancy  quantitation 





Development  of  a  procedure  that  allows  in‐depth  analysis  of  posttranslational 
modifications  of  linker  histones  –  Mass  spectrometry  based  identification  of 
posttranslational  modifications  require  digestion  of  proteins  to  peptides.  Usually 
trypsin or another residue specific endoproteinase enable cleavage of proteins  into 





To  improve  the  sequence  coverage  of  analyzed  H1  we  separated  off‐line  tryptic 
peptides of H1 and then analyzed individual fractions using a chip implementation of 
nanoelectrospray coupled to a linear ion trap‐Orbitrap hybrid instrument (18). In this 
approach  partially  purified  linker  histones  were  digested  with  trypsin  and  the 
resulting peptides were separated into 11 fractions on a C18 column in the presence 
of  a  high  concentration of  ion‐pairing  reagent  (Fig.  1).   A  comparison of  the data 
obtained  using  this  approach  and  using  the  standard  LC‐MS  setup  revealed  clear 










Relative  quantitation  of  linker  histone  methylation  –  In  respect  to  abundance, 
phosphorylation  is  the  most  prominent  posttranslational  modification  in  linker 
histones  and  has  been  studied  extensively using  biochemical methods  in  the past 
(14,23).  In contrast,  little  is known about  the abundance of other posttranslational 
modifications  that  have  recently  been  discovered  using  high  performance  mass 
spectrometry      (10,16,24).  In  our  previous work, we  have  already  introduced  the 








we  have  synthesized  peptide  pairs  of  methylated  and  non‐methylated  peptide, 
corresponding to the tryptic peptides 26‐32 and 65‐75 of H1.4 and peptide 27‐35 of 
H1.5.  Measurements  of  ion‐intensities  revealed  1.3‐2.0  fold  higher  ionization 
efficiencies of  the methylated peptides  in comparison  to  their non‐modified  forms 
(Table 1). For relative quantitation of methylation at K‐26 and K‐75 of H1.4 and K‐27 
of  H1.5  the  ratio  of  intensities  between  modified  and  unmodified  peptide  were 
normalized using  the values  shown  in Table 1. For normalization of  the extents of 
other methylations we  used  an  average  value  of  1.5.  For methylation  sites  other 













(Fig.  3,  panel A)  and  the  intensity  values  are  directly  proportional  to  the  peptide 
concentration over a dynamic  range used  for peptide quantitation  (Fig.3, panel B). 
Over  a wide  range  of  peptide  concentrations  the  observed  signal  intensity  had  a 
standard deviation below 10% (Fig. 3, Panel C).  
 
Mapping  of  posttranslational  modification  in  human  tissue  –  Samples  of  breast 
cancer  and  normal  breast  were  used  to  map  posttranslational  modifications  in 
human  tissue.  In  addition  to  previously  described  sites  of  acetylation, 
phosphorylation,  and  formylation  sites  (10,24)  we  found  several  sites  of  lysine 
monomethylation in H1.0, H.1.2 H1.3, H1.4 and H1.5 (Table 2). In linker histone H1.0 







1).  In  the  variant  H1.5  methylation  at  K‐27,  a  site  resembles  K‐26  at  H1.4,  was 




ionization‐supportive  property  and  low  background.  Since  recent  work  (25)  has 
demonstrated  that glutamic acid can partially be methylated  in a buffer containing 
methanol,  we  analyzed  carefully  every  methylation  site.  We  found  that  several 
peptides  occurred  in  two  forms  with  either  methylated  lysine  or  with  methyl 
glutamate. Both peptide forms have  exact the same precursor ion mass, as shown in 
the MS/MS spectra of Fig.3A and E, supplementary Fig.1B. For this reason we do not 
consider  several  methylated  peptides  with  adjacent  glutamic  acid  and  lysine 






(including  SETAPAAPAAAPPAEK  (2‐21,  H1.2),  SETAPAAPAAPAPAEK  (2‐17,  H1.4), 
SETAPAETATPAPVEK (2‐17, H1.5), YSDMIVAAIQAK (28‐40, H1.0), ALAAAGYDVEK (65‐
75, H1.2‐4)  , ALAAGGYDVEK  (68‐78, H1.5))  because we missed  clearly  assigned  y1  
ions  in  the  MS/MS  spectra.  In  these  cases  it  was  not  possible  to  differentiate 
between esterified glutamic acid and methylated lysine solely by b‐ions which easily 












grade  2  cancer  and  adjacent  normal  breast.  Analysis  of  the  methylation  extents 





This study provides  first  insights  in posttranslational modifications of  linker histone 
variants in human tissues. We show that in both normal and in breast cancer tissue 
lysine  methylation  is  the  second,  after  phosphorylation,  most  abundant 
posttranslational modification of  linker histones. Our  results emphasize differences 
between  tissue  and  cultured  cells  reported  previously  (10).  Whereas  in  cultured 
breast and cervical cancer cells lysine multiple sites of lysine acetylation were found 
and  only  little  lysine  methylation  was  observed.  In  contrast,  in  linker  histones 
isolated  from  mouse  tissues  methylation  appeared  to  be  more  frequent.  Two 






methylation  sites were  identified  in NTDs of mouse H1.1, H1.2,  and H1.3,  and  six 
sites in the GH1 were mapped in different H1 variants. In this study, using improved 
method  of  analysis, we  identified most  of  these  sites  in  human  tissue  as well  as 
identified  additional  methylation  sites.  Resembling  methylation  of  mouse  linker 





the  from  the  N‐terminus  first  lysine  of  H1.0  and  the  second  at  the  previously 
reported  K‐26  in  H1.4  (16),  as  well  as  methylation  of  K‐27  of  H1.5  resembles 






The  mechanism  and  substrate  specificity  of  enzymes  involved  in  methylation  of 
linker histone are not identified yet. Two major features of methylation of H1 can be 
seen  from  our  results.  First,  extends  of  the  methylation  correlate  with  the 
abundance of  individual variants  (Fig. 1, chromatogram A). H1.4 which  is  the most 
abundant human variant of H1 is more methylated than less abundant H1.5 and H1.2. 
The methylation extents are  lowest  in the H1.0 which occurs at  lowest  levels when 
compared  to  the  other  analyzed  variants.  Since  it  is  rather  less  probable  that  for 
example H1.4 is a better substrate for methyltransferases than other H1 variants the 
differences  in H1 methylation can be explained in terms of enzyme kinetics. In such 
case  the  effective  concentrations  of  individual H1  variants  lie  in  the  range  of  Km 
(acceptor) of  the methyltransferase and  therefore moderate differences  in protein 
concentration result in higher changes in the methyl transfer.  
 






The  second  feature  of  H1  methylation  is  its  N‐terminal  polarization.  The  most 
abundant methylation site is located in NTD, the moderately methylated lysines are 
in GH1, and  little methylation occurs  in CTD. The distribution of the methylation  in 
H1  inversely  reflects  charge  distribution  of  linker  histones  with  highest  positive 
charge  density  in  CTD  and  the  lowest  in  NTD.  The  major  function  of  CTD  is 
nucleosome  binding  and  stabilization  of  chromatin  folding  (27),  thus  it  is  possible 




For  several  reasons proteomic  analysis of  solid human  tissues  is not an easy  task. 
These  include  genetic  or  age  related  variation  between  individuals  and 
heterogeneity of tissue sample which is usually composed of different types of cells. 
In single cases cancer cells are often mixtures of cells that are classified to different 
grades  (30).  Laser  dissection  is  normally  introduced  to  select  single  type  of  cells. 
However, due to the laborious procedure, very limited amount of sample is available 
by  this  method  and  which  is  normally  not  enough  for  post‐translational 
modifications  analysis.  Tissue  storage  and  extraction  procedures  can  additionally 
contribute  to  variability  of  the  results.    Our  analysis  clearly  demonstrates  how 
difficult  it  is to analyze and problematic  it can be to draw conclusions  from studies 
on  human  tissue.  Quantitative  mapping  of  methylation  sites  revealed  high  level 
variability between individual samples. Since all samples were stored, processed, and 
analyzed  in  the  same way, we  believe  that  observed  variation  reflects  solely  the 
nature  of  individual  samples  and  that  it  reflects  activities  of  endogenous 
methyltransferases.  
 
Despite  high  differences  in  the methylation  extent  between  samples  of  different 











Another  study  demonstrated  an  ability  of  EZH2  to  modify  H1  (33),  but  the 
methylated  lysines were not mapped.  Further work  should provide more detailed 
map of methyl‐acceptor‐lysines in H1 upon action of this methyltransferase.   
 
In  contrast  to  acetylation,  which  is  usually  related  to  transcriptional  activation, 
methylation of histones results in either activation or repression of transcription. The 
effect  of  methylation  depends  on  the  modified  residue  and  simultaneous 
posttranslational modification of other  residues of a histone.  So  far more  than 10 
different histone methyltransferases were characterized  in humans (34). Moreover, 
enzymatic  lysine  demethylation  process  has  been  described  (35,36).  Thus,  by 
analogy  to  core  histones,  properties  of  linker  histones  appear  to  be  regulated  by 
methylation of lysine residues.  
 
Our  present  and  the  previous  study  on  posttranslational  modification  of  linker 
histones  (10)  provide  a  relative  complex  picture.  In  addition  to  multiple 
phosphorylation sites  that have been extensively studied  in  the past, we  identified 
multiple sites of  lysine acetylation and methylation. Furthermore,  lysine residues  in 
H1 are frequently formylated (24). In human cultured cells acetylation appear to be 
the  more  abundant  than  methylation,  whereas  in  mouse  and  human  tissue 
methylation  appears  to  be more  prominent  (10). Our  data  suggest  that  elevated 
methylation  in  tissues  reflects  higher  extent  of  transcriptional  silencing  in  tissue, 
including  tumor  in  comparison  to  cultured  cells.  However,  we  are  far  from 
elucidation  of  the  role  of  posttranslational  modifications  in  H1.  Moreover,  our 
studies  on  linker  histones may  raise  a  question  of  relevance  of  cultured  cells  as 
model system for studying cancer (10). 
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Figure1.  Overview  of  the  method  used  for  mapping  of  posttranslational 
modifications  of  linker  histones.  Frozen  tissues were  homogenized  in  5%  HClO4. 
HClO4 soluble proteins were precipitated with Cl3CCOOH and chromatographed on a 
C18  reverse  phase  column.  Proteins  were  eluted  with  CH3CN  gradient  in  0.1% 
F3CCOOH. Three  fractions  containing H1.0, H1.5  and H1.2‐H1.4,  respectively, were 









in Triversa‐  (A, C) and LC‐MS/MS  (B, D) analysis.   n,    the number of experiments. 
NTD, N‐terminal domain; GH1, globular domain of H1, CTD, C‐terminal domain. 
 
Figure  3.  Linear  range  and  error  of  the  quantitation  method.  The  quantitation 
method  was  analyzed  for  linearity  and  reproducibility  using  synthetic  peptides 
mKAAGAGAAK and KAAGAGAAK that were electro‐sprayed either individually or as a 
mixture  over  a  wide  range  of  their  concentrations.  (A)  Correlation  of  intensities 
obtained from MS based and XIC based measurements. B) Estimation of the linearity 
range of  the quantitation method. Mass peak  intensities  for peptide concentration 











Figure 6. Summary of  identified methylation  sites  in  linker histone variants H1.4 
including sites matched by the sequences of H1.2 or/and H1.3 (A), H1.2 specific (B), 
H1.5 (C) and H1.0 (D). NTD, N‐terminal domain; GH1, globular domain of H1, CTD, C‐
terminal domain. Black and grey bars  represent values measured  in normal  tissue 






































H1.4  K‐26  26‐32  mKSAGAAK / KSAGAAK  0.97  1.30  1.34 
H1.5  K‐27  27‐35  mKAAGAGAAK / KAAGAGAAK  0.58  1.15  2.00 
H1.2‐H1.4  K‐75  65‐75  ALAAAGYDVEmK / ALAAAGYDVEK  0.97  1.25  1.29 
 














H1.0  K12  2‐12  TENSTSAPAAmK  ‐‐‐  ‐‐‐ 
K82  75‐82  LVTTGVLmK  0.15% (1/4)  0.10% ± 0.13% (3/7)* 
K102  98‐102  SDEPmK  ‐‐‐  ‐‐‐ 
K108  104‐108  SVAFmK  0.02% (1/4)  0.21% ± 0.21% (3/7) 
K155  150‐155  LAATPmK  0.02%±0.02% (4/4)  0.05% ± 0.05% (6/7) 
H1.2  K168  160‐168  KPAAATVTmK  0.003%±0.003%(3/4)  0.26% ± 0.54% (5/6) 
H1.2; 
H1.3; H1.4 
K52  47‐52  AVAASmK  0.22% ± 0.13% (4/4)  0.12% ± 0.08% (6/6) 
K64  55‐64  SGVSLAALKmK  0.96% (1/4)  0.70% ± 0.23% (2/6) 
K97  91‐97  GTLVQTmK  0.02% ± 0.03%(3/4)  0.65% ± 0.56% (2/6) 
K106  98‐106  GTGASGSFmK  0.021% (1/4)  0.09% ± 0.06% (2/6) 
H1.2; H1.4  K119  111‐119  AASGEAKPmK  ‐‐‐  ‐‐‐ 
H1.4  K26  26‐32  mKSAGAAK  11.2% ± 2.87% (4/4)  20.4% ± 13.4% (6/6) 
  K148  140‐148  KATGAATPmK  0.003%±0.001%(3/4)  0.03% ± 0.05% (5/6) 
H1.5  K27  27‐35  mKAAGAGAAK  0.65 % ± 0.43% (3/3)  2.22% ± 3.56% (6/6) 
*in brackets are given the number of identifications / number of samples. 
‐‐‐ means the site could not be truly quantified due to artifact glutamic acid methylation with the same nominal precursor ion mass


























































































































































































































6 Comparative membrane proteomics from three rat 
nerve tissues 
 
6.1 Publication: Comparative Proteomic Profiling of Membrane Proteins in Rat 
Cerebellum, Spinal Cord, and Sciatic Nerve 
 
This manuscript contains the results from the project of membrane protein identification 
from three rat nerve tissue. The following pages contain the draft of the manuscript, 
which is being submitted to Journal of Proteome Research. 
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Proteomics is an increasingly powerful technology that can provide in-depth 
insights into entire proteomes and their variation upon disease. Large scale 
proteomics today enables identification and measurement of changes of 
thousands of proteins from minute amount of tissues. Here we provide a 
comparative proteomic profile of three distinct parts of the murine nerve system: 
cerebellum, spinal cord, and sciatic nerve. Since membrane proteins are the key 
regulators of neural transmission and memory, our analysis is focused on this 
group of proteins. Rat tissues were homogenized and extracted to remove non 
membrane proteins and the resulting membranes were solubilized with 
detergents. Proteins were fractionated by size exclusion chromatography, 
depleted for detergents, digested and analyzed by LC-MS/MS using LTQ-
Orbitrap Instrument. Applying stringent identification criteria in total 4,124 
proteins were identified. Of these proteins 3,528, 3,290 and 1,649 were mapped 
to cerebellum, spinal cord and sciatic nerve, respectively. Our analysis allowed 
an in-depth mapping of neurotransmitter receptors, ion channels, and transporter 
proteins.  This work is the most in-depth proteomic analysis of nerve tissues to 
date and provides the first unbiased insights into the proteomes of anatomically 
and functionally distinct parts of the membrane proteome of the central and 
peripheral nerve systems. The methods applied here can be directly applied to 
studying nerve systems and their disorders.  
  







Whereas traditional biochemical methods allow studying limited numbers of 
proteins, proteomics potentially can provide insights into the entire proteome. 
This modern approach has the potential to uncover differences between 
diseased and normal tissues in terms of single proteins, their posttranslational 
modifications, and protein-protein interactions as well as on a global scale such 
as analysis of signaling pathways and biological processes. In particular 
proteomic methods have frequently been applied to study brain, brain 
compartments, and other nerve tissue in respect to neural diseases1. 
Unfortunately, due to use of premature or inappropriate proteomic approaches 
the vast majority of these attempts provided only very incomplete pictures with 
limited value for understanding neural disorders. Technological limitations of the 
past were mainly of preparative origin including protein extraction, separation, 
and enzymatic digestion for mass spectrometric analysis. A case in point is the 
use of two-dimensional electrophoresis for protein separation and quantification. 
It has become apparent the 2D gels are particularly inadequate technique for 
studying tissues such as brain, providing biased datasets almost exclusively 
restricted to housekeeping proteins and with a very low content of membrane 
proteins such as ion channels and receptors [reviewed in 2].  Owing to their 
unique properties, membrane proteins are likely to play an important role in 
etiology of diseases of nerve. Therefore techniques allowing detection and 
characterization of membrane proteins are a prerequisite for proteomic studies 
on neuronal disorders.   
 
In parallel to 2DE based approaches, gel free approaches for proteomic analysis 
of membrane proteins, including their relative and absolute quantification, have 
been developed in recent years.  Since many membrane proteins are low 
abundant, enrichment of membranes or isolation of specific type of membranes 
such as the plasma membrane is essential for an extensive analysis of these 
proteins. For this purpose proteomics specific extraction techniques were 





developed for purification of total membranes3, 4 and for plasma membrane 
enrichment5, 6. To quantify proteins, stable isotope tags such as ICAT and 
HysTag were developed7, 8 and successfully applied for labeling of membrane 
proteins8-10.  As an alternative way for relative quantification of mouse brain 
plasma membrane proteins label-free approaches were developed11, 12.  Using a 
novel extraction and purification method and using “diagonal” reverse-phase 
peptide fractionation method13 we have previously identified 1,700 proteins in 
mouse hippocampus5. Combining the plasma membrane purification method with 
the HysTag-labeling technique we have quantified 555 plasma membrane 
proteins between cortex, cerebellum and hippocampus of mouse brain. In 
another study membrane proteins from mouse fore- and hindbrain were analyzed 
using label-free technology, resulting in relative quantification of 967 proteins14.  
 
The nervous system of vertebrates consists of the central (CNS) and the 
peripheral nervous systems (PNS). Brain and spinal cord are the components of 
CNS. Whereas the vast majority of proteomics studies have been focused on 
profiling components of the entire brain or its parts such as hippocampus, 
cerebellum, and cortex, less attention has been paid to spinal cord15-20 and 
studies attempting to analyze proteome of the PNS are scarce21.  
 
In this work we compared membrane proteomes of three distinct parts on the 
vertebrate nerve system: the cerebellum, spinal cord, and sciatic nerve. Our 
study provides the most comprehensive protein profile of nervous tissues to date. 
Applying stringent identification criteria, in total, 3,528, 3,290 and 1,649 proteins 
were identified from rat cerebellum, spinal cord and sciatic nerve, respectively. 
More than 70% of these proteins are annotated as membrane proteins. The in-
house developed MaxQuant algorithms (Cox and Mann, submitted to Nature 
Biotechnology) allowed us to compare the abundance of the individual proteins 
between the three distinct parts of the nerve system.  Our results provide an 
unprecedented depth of coverage of the nervous systems proteome. It allows 
comparative proteomic assessment, enabling insights into the membrane 





proteomes of anatomically and functionally distinct parts of the central and 
peripheral nerve systems.  
 





Materials and Methods 
 
Membrane Proteins Extraction. The protocol applied here was slightly modified 
from the one published earlier in our group5. Briefly, 40-50 mg of frozen rat 
cerebellum, spinal cord, or sciatic nerve (Pel-freez Biologicals®, Rogers, AR) 
were blended in 1 ml of high salt buffer (2M NaCl, 10 mM HEPES-NaOH, pH 7.4, 
1 mM EDTA) using IKA Ultra Turbax blender (IKA-Ultra Turrax, Staufen, 
Germany) at maximum speed for 20 seconds. The suspensions were centrifuged 
at 16,100 x g for 15 min in an Eppendorf 5145R centrifuge. The pellets were re-
extracted twice in 1 ml of carbonate buffer (0.1 M Na2CO3, 1 mM EDTA). 
Subsequently the pellets were washed with 1 ml of urea buffer (4 M urea, 100 
mM NaCl, 10 mM HEPES-NaOH, pH 7.4, and 1mM EDTA). After centrifugation 
the pellets were suspended in 100 µl 100mM CHAPS in PBS and were gently 
stirred at 20°C for 18h. After centrifugation, the pellets were re-extracted with 2% 
SDS in 0.1 M Na-phosphate buffer, pH 7.0 at 20°C for 18 h.  
 
Size exclusion chromatography. Detergent dissolved proteins were 
chromatographed on Superdex 200 10/300GL column (GE bioscience) using 
Shimadzu UFLC chromatographic system (Kyoto, Japan). PBS containing 0.2% 
SDS was used as the mobile phase. Proteins were eluted at a flow rate of 250 
µl/min and 400 µl fractions were collected.  
 
Ethanol precipitation. One ml absolute ethanol was added to every 400 µl 
fraction. After 8h incubation at -20 °C precipitated proteins were collected by 
centrifugation at 16,000 x g at 4 °C. The pellets were washed 3 times with 70% 
ethanol and dried. 
  
In solution digestion and peptides desalting. Detergent-free protein fractions 
were dissolved in 50 µl 8M urea and digested with 0.5 µg of Lys-C at room 
temperature for 4h. Subsequently, 150 µl of 50mM NH4HCO3 were added and 





the digestion was continued room temperature in the presence 0.5 µg of trypsin 
(Promega, WI) for 4h. Digestion was terminated by adding 1% TFA and the 
tryptic peptides were desalted on RP-C18 StageTip columns22. 
 
Nano-HPLC-MS/MS. All Nano-HPLC-MS/MS experiments were performed using 
an Agilent 1100 nanoflow system (Agilent Technologies, Palo Alto, CA) 
connected to a linear ion trap-orbitrap hybrid mass spectrometer (LTQ-Orbitrap, 
Thermo Fisher Scientific, Bremen, Germany) equipped with a nanoelectrospray 
ion source (Proxeon Biosystems, Odense, Denmark) as described before23. The 
reversed phase capillary emitter column was 15 cm length, 75 µm inner diameter, 
and in-house packed with 3 µm ReproSil-Pur C18-AQ media (Dr. Maisch GmbH, 
Ammerbuch-Entringen, Germany). The sample was separated by a 120 min 
gradient from 2% acetonitrile to 80% acetonitrile. Data acquisition on LTQ-
orbitrap was operated in the data-dependent mode. Survey MS scans were 
acquired in the orbitrap at a resolution of 60,000. Up to the 7 most intense ions 
per scan were fragmented and detected in the linear ion trap. The online lock-
mass option was utilized in order to improve mass accuracy24.  
 
Database searching and validation. The MS raw data was analyzed using the 
software MaxQuant25 version 1.0.9.3, and then searched with the MASCOT 
engine against decoy IPI-rat database version 3.39. No fixed modification was 
applied, whereas protein N-terminal acetylation and methionine oxidation were 
set as variable modifications. Up to 2 missed cleavages were allowed for Lys-C 
digestion. The precursor ions were matched with an initial 7 ppm maximum mass 
deviation (MMD26) and the fragment ions had to match within an MMD of 0.4Da. 
The Mascot data were again imported into MaxQuant and parsed using the 
following criteria: (a) Peptide lenght of at least six amino acids and (b) the false 
discovery rate at both protein and peptides level lower than 0.01. “Match 
between runs” was ticked on during parsing, which means the precursor ions 
identification was transferred to unsequenced peptides based on elution time 
(±0.5 min) and accurate mass (within 2 X STD of the mass identified in other 





runs) by comparing the same ion identified in other runs in which MS/MS 
fragmentation was performed. After the parsing, the proteins identified with at 
least two peptides, of which at least one was unique to the protein (or protein 
group) were considered to be genuine hits. The complete lists of identified 
proteins and peptides are in supplementary table 1 and 2, respectively. 
 
Bioinformatics analysis. Protein localization and membrane and 
transmembrane domain annotation analyses were performed using Protein 
Center platform Version 1.3.3 (Proxeon Biosystems, Odense, Denmark) in which 
GO annotation and TMAP (http://emboss.sourceforge.net/apps/tmap.html) for 
transmembrane domain prediction are integrated. The KEGG overrepresentation 
analysis was performed by hypergeometric test using cytoscape27 plugin BiNGO 
2.028. Briefly, a custom KEGG ontology containing mapping from rat EntrezGene 
identifiers to KEGG pathway identifiers was created for all the rat proteins, which 
served as the reference set. Subsequently, our identified proteome i.e. the test 
set was mapped to EntrezGene identifiers and analyzed for overrepresented 
pathways with respect to the reference set. Pathways with p-value < 0.01 were 
considered to be significant.  







There are many factors affecting the quality and the depth of a proteomic 
analysis. The main ones are the sample preparation, the mass spectrometric 
setup, and the data analysis. For the comparative proteomic study on cerebellum, 
spinal cord and sciatic nerve, we have applied a high resolution liquid 
chromatography tandem mass spectrometry system (LC-MS/MS) and the 
acquired high accuracy data were analyzed using the identification and 
quantification software MaxQuant developed in our group. As a reduction of 
sample complexity is a prerequisite for identification of proteins occurring at low 
abundance, we have used a three-step enrichment and fractionation protocol of 
membrane proteins. This protocol included purification of membranes, differential 
detergent-based extraction, and size exclusion chromatography of membrane 
proteins. The results provide first in-depth insights into the proteomes of three 
anatomically distinct parts of the central and peripheral nervous systems (CNC 
and PNS). 
  
More than 4,000 proteins were identified in three tissues. The entire 
procedure for analysis of the nerve tissues is summarized in Fig.1. Crude 
membrane fractions were prepared by successive depletion of non-membrane 
proteins with high salt, sodium carbonate, and 4M urea4. Proteins were 
subsequently extracted from the membranes using CHAPS and SDS to achieve 
a partial separation of proteins according their solubility in the detergents. Each 
of the extracts was fractionated by means of size exclusion chromatography into 
10 factions. After removal of detergent, proteins were digested with 
endoproteinase Lys-C and trypsin, and analyzed by LC-MS/MS. 
 
For protein identifications we have applied very stringent identification criteria 
(see Methods). The accuracy of mass determination is exemplified in Fig. 2 for 
peptides originating from the cerebellum. The average mass deviation for all the 
peptides identified in cerebellum was -0.0688ppm, and the standard deviation 





was 1.098 ppm.  Similar values were observed for spinal cord and sciatic nerve 
peptides.  
Using these criteria in total 4,124 proteins were identified. Of these 3,528, 3,290, 
and 1,649 were mapped to cerebellum, spinal cord, and rat sciatic nerve (Table 1, 
Fig. 3). A total of 70-75% of the proteins were annotated in GO-database as 
membrane proteins and 52-58% of the proteins have at least one predicted 
transmembrane domain (Table 1, Fig. 3).  According to GO cellular compartment 
analysis proteins from plasma membrane, ER, and nucleus were most 
abundantly represented (up to 20%) (Table 1, Fig. 4).  
 
GO molecular function and biological process analysis. GO molecular 
function and GO biological process distribution pattern of identified proteins were 
similar for each analyzed nerve tissues (Table 2). Figure 5A shows an example 
of the proteins identified from rat cerebellum. Approximately 22% of all identified 
proteins have catalytic activity function, followed by protein binding (21%), 
nucleotide binding (10%) and metal ion binding activity (9%). More interestingly, 
around 8% and 4% of proteins were annotated as transporters and receptors, 
respectively. The nature of these proteins is discussed in more detail in the 
sections below. GO biological process annotation analysis revealed that 14% 
and 12% proteins are involved in transport and cell communications, respectively 
(Figure 5B).   
 
More than 100 genes were identified in at least two splice forms. For protein 
identification, only the proteins (group) with at least one unique peptide were 
accepted. Proteins containing the same identified peptides but no unique ones to 
differentiate each other were grouped together as a single identification. Using 
MaxQuant software we were able to differentiate at least two different protein 
isoforms from 129 genes (Supplementary Table 3, in total 276 proteins). Out of 
260 annotated splice isoforms, 211 (81.2%) proteins were annotated as 
membrane proteins.  
 





Neurotransmitter receptors. Neurotransmitter receptors can be grouped into 
two broad classes: the ligand-gated ion channels (ionotropic) and the G-protein 
coupled (metabotropic) receptors. Whereas ligand-gated ion channels mediate 
rapid postsynaptic responses, G protein-coupled receptors mediate slow 
postsynaptic responses. In our study, we identified in total 21 glutamate 
receptors, 13 γ-aminobutyric acid (GABA) receptors and 3 glycine receptors 
(Table 3).  
  
Glutamate Receptors. L-Glutamate is the most abundant excitatory 
neurotransmitter in the mammalian nervous system. Ionotropic glutamate 
receptors appear to be tetrameric 29 or pentameric30, and consist of four groups: 
N-methyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic 
acid (AMPA), kainate receptor, and glutamate receptor δ1 and 2. The 
metabotropic glutamate receptor (mGlur) family consists of eight different types 
of subunits: mGluR1 to mGluR8 that can be subdivided into groups I, II, and III 
based on receptor structure and physiological activity. 
 
In rodents, two groups of NMDA receptor subunits were defined as NR1 (ζ1, 
gene: Grin1) and NR2A-D (ε1-4, gene: Grin2a-d). The NR1 protein can form 
homomeric channels whereas the NR2 subunits form functioning channel only as 
heterodimers with the NR1 subunit31, 32. In our study, we identified two splice 
variants of NR1, NR2A and NR2C in the rat cerebellum. The two splice variants 
of NR1 shares 11 identified peptides with one differentiating them from each 
other.  In spinal cord, only one isoform of NR1 was identified. We failed to identify 
this group of proteins in the sciatic nerve, which may indicate relatively low 
expression levels in the nerve. 
  
AMPA receptors are composed of four types of subunits, designated as GluR1 
(Gria1), GluR2 (Gria2), GluR3 (Gria3), and GluR4 (Gria4). Most AMPA receptors 
are heterotetrameric, consisting of symmetric 'dimer of dimers' of GluR2 and 
either GluR1, GluR3 or GluR4 (ref33). Not only all four subunits but also two 





splice isoforms for GluR1, GluR3 and GluR4 in were identified in rat cerebellum. 
In spinal cord, GluR2 and two splice forms of both GluR1 and GluR3 were 
identified. In sciatic nerve, GluR2, one splice form of GluR1 and two splice forms 
of GluR3 were identified.  
 
There are five types of known kainate receptor subunits, GluR5 (Grik1), GluR6 
(Grik2), GluR7 (Grik3), KA1 (Grik4) and KA2 (Grik5). In our study, GluR6 was 
identified in all three tissues, whereas GluR7 was identified in cerebellum and 
spinal cord. 
 
The glutamate receptor, iontropic, δ1 (Grid1) and δ2 (Grid2) are another group of 
members of the family of ionotropic glutamate receptors. GluR-δ2 has been 
found to be expressed selectively in cerebellar Purkinje cells 34. We identified the 
GluR-δ2 protein in all three tissues as well as GluR-δ2 interacting protein 1 
(Grid2ip). GluR-δ1 was identified in the cerebellum and spinal cord. 
 
Of the eight types of metabotropic glutamate receptors, we identified mGluR1, 
mGluR2, mGluR3 and mGluR 4 in all three tissues, mGluR7 in cerebellum and 
spinal cord, and mGluR5 in spinal cord only.  
 
GABA receptors. GABA is the key inhibitory neurotransmitter in the vertebrate 
central nervous system. It acts through three classes of receptors: two types of 
ligand-gated GABAA and GABAС chloride channels and GABAB receptors that 
are coupled to separate K+ or Ca2+ channels via G-proteins. Most GABAA 
receptors are assembled from subunits to form a hetero-pentameric structure, 
and in the rodent brain, they appear to be quite heterogeneous and comprise six 
different α-subunits (α1 - α6), three β-subunits (β1 - β3), three γ-subunits (γ1 - 
γ3), one δ-subunit and two more candidate ε-subunit and θ-subunit35. We 
identified α1, α2, α3, α5 and α6 in rat spinal cord, α1, α2 and α6 in cerebellum, 
and α1 and α6 in sciatic nerve. β1 - β3 were identified in cerebellum, whereas β1 
and β3 were found in spinal cord, and β2 and β3 in sciatic nerve. γ1 and γ2 were 





identified in both cerebellum and spinal cord, whereas only γ2 was identified in 
the sciatic nerve. The δ-subunit was also identified in the rat cerebellum and 
sciatic nerve. GABAB subunit-1 and 2 were identified in the three tissues. 
 
Glycine receptor.  Glycine receptors are widely distributed inhibitory ligand-gated 
ion channels in the central nervous system. Four α-subunits (α1 - α4) and a 
single β-subunit are known. In our study, α3and β subunits were identified in both 
the cerebellum and spinal cord, whereas α1 was only identified in the spinal cord. 
 
Ion channels. Ion channels are pore-forming proteins that help to establish and 
control the voltage gradient across the plasma membrane of all living cells by 
allowing the flow of ions down their electrochemical gradient. Classified by the 
nature of their gating, ion channels can be divided into voltage-gated ion 
channels and ligand-gated ion channels.  As the name indicats, voltage-gated ion 
channels activate/inactivate depending on the voltage gradient across the 
plasma membrane, whereas ligand-gated ion channels activate/inactivate 
depending on binding of ligands to the channel. In total, we identified 14 voltage-
gated calcium ion channels, 11 voltage-gated potassium ion channels, 9 voltage-
gated sodium ion channels and 10 chloride channels (Table 4).  Furthermore, 12 
other potassium ion channels belong to other subfamilies (supplementary table 
1).   
 
Voltage-dependent calcium channels. Voltage-dependent calcium channels are 
formed as a complex of several different subunits: α1, α2δ, β1-4, and γ. The α1 
subunit has 24 putative transmembrane segments and forms the ion conducting 
pore with four homologous repeated domains while the other three subunits have 
several auxiliary functions including modulation of gating36. In our study, by using 
the nomenclature suggested by Ertel EA et al37, out of 10 cloned α1 subunits, we 
identified Cav2.1 (Cacna1a, 2 isoforms), Cav2.2 (Cacna1b), Cav2.3 (Cacna1e) 
and Cav3.1 (Cacna1g) in rat cerebellum, Cav2.1 (1 isoform) and Cav2.3 in spinal 
cord and Cav2.1 (1 isoform) in sciatic nerve. Subunits α2δ1-3 (Cacna2d1-3) were 





clearly identified in cerebellum and spinal cord, while only α2δ1-2 were clearly 
assigned to the sciatic nerve. Subunits β2 (Cacnb2) and β3 (Cacnb3) were only 
identified in rat cerebellum. The subunits β4 (Cacnb4) was identified in both 
cerebellum and spinal cord but we could not differentiate it from β1 subunits due 
to their high sequence similarity. Five peptides specifically different from other 
subunits but shared by them were assigned. In the last group of γ subunits, we 
identified γ2 (Cacng2), γ5 (Cacng5), γ8 (Cacng8) in the rat cerebellum. γ2 and γ8 
subunits were identified in both spinal cord and sciatic nerve.  
 
Voltage-dependent potassium channels. Potassium-selective channels are the 
largest and most diverse group of ion channels. Functional voltage-gated Kv 
channels are formed by either homotetramer or heterotetramer of Kv1, Kv7, and 
Kv10 families. Kv5, Kv6, Kv8, and Kv9 families encode subunits that act as 
modifiers, and β subunits, KCHIP1 (Kv4), calmodulin (Kv10), and minK (Kv11) 
serve as the accessory proteins associate with Kv tetramers and modify their 
properties 38. We identified Kv1.1 (Kcna1), Kv1.2 (Kcna2), Kv1.3 (Kcna3), Kv1.4 
(Kcna4), Kv1.6 (Kcna6), Kv7.2 (Kcnq2), Kv10.1 (Kcnh1) or Kv10.2 (Kcnh5) as the 
core channels to form the “pore” in rat cerebellum. No Kv modifier was identified 
in the study, but as accessory proteins we identified two isoforms of β2 protein, 
Kv4.2 (Kcnd2) and Kv4.3 (Kcnd3) in rat cerebellum. Subunits Kv10.1 (Kcnh1) and 
Kv10.2 (Kcnh5) cannot be clearly differentiated in cerebellum with unique 
peptides. All subunits were identified in cerebellum except Kv10.1 or Kv10.2, 
which were identified in spinal cord. Only two subunits Kv1.1 and Kv1.2 were 
found in the sciatic nerve.  
 
Voltage-dependent sodium channels. The voltage-gated sodium channel in 
mammalian neuron is a large, multimeric complex, composed of a 260 kDa α 
subunit and one or more 33-36 kDa β subunits39. The α subunit is predicted to 
fold into four similar domains (I-IV) and each contains six α-helical 
transmembrane segments (S1-S6). The ion-conducting aqueous pore is 
contained entirely within the α subunit. The essential elements of sodium-channel 





function, e.g. channel opening, ion selectivity and rapid inactivation can be 
demonstrated when α subunits are expressed alone in heterologous cells 40. 
Coexpression of the β subunit modifies the kinetics and voltage-dependence of 
the gating of the channel and is required for full reconstitution of the properties of 
native sodium channels 40. Five α subunits (Navα1.1(Scn1a), Navα1.2(Scn2a1), 
Navα1.4(Scn4a) or Navα1.5(Scn5a), Navα1.6(Scn8a) and an unknown Nax sub-
family (Scn7a)) and three β subunits (Navβ1(Scn1b), Navβ2(Scn2b), 
Navβ4(Scn4b))  were identified in rat cerebellum. In rat spinal cord, three α 
subunits (Navα1.1, Navα1.6 and Nax) and four β subunits (Navβ1, Navβ2, Navβ3 
(Scn3b) and Navβ4) were identified. In the rat sciatic nerve, one α subunit (Nax) 
and two β subunits (Navβ2 and Navβ4) were found.  
 
Chloride channels. Chloride channels consist of approximately 13 members and 
are important for setting cell resting membrane potential and maintaining proper 
cell volume. Unlike the specific ion transmission of the cation channel described 
before, these channels conduct Cl- as well as other anions such as HCO3-, I-, 
SCN-, and NO3-. The chloride channel proteins identified in cerebellum include 
chloride channel protein 2 (Clcn2), 3 (Clcn3), 4 (Clcn4-2), 5 (Clcn5), 6 (Clcn6), 7 
(Clcn7), chloride intracellular channel protein 1 (Clic1), 4 (Clic4) and chloride 
channel CLIC-like protein 1 (Clcc1).  Besides the proteins listed above, one long 
isoform encoding a form of the Clcn3 gene was also identified in the spinal cord. 
In the sciatic nerve, only chloride channel protein 6 and chloride intracellular 
channel protein 1 and 4 were identified. 
 
Multidrug resistance proteins (MRPs) and ATP-binding cassette 
transporters (ABC). The ABC genes represent the largest family of 
transmembrane proteins. These proteins are classified as ABC transporters 
based on the sequence and organization of their ATP-binding domains, also 
known as nucleotide-binding folds NBFs41. Since the first discovery in 1976 (ref42) 
that it was possible for one of the ABC transporter P-glycoprotein (P-gp/MDR1, 
Abcb1) to confer resistance to a relatively large number of structurally diverse 





drugs with different mechanisms of action, 11 more ABC transporters were found 
to be involved in drug resistance, including MPR1-6 (Abcc1-6), MRPs 7-9 (Abcc 
10-12), MRP10 (Abcc13) and ABCG2/BCRP (Abcg2)41,43. Out of 27 identified 
ABC transporters in our study (Table 5), 5 multidrug resistance proteins, 
including P-gp/MDR1 (Abcb1), MDR2 (Abcb4), MRP1 (Abcc1), MRP4 (Abcc4) 
and ABCG2/BCRP (Abcg2) were identified. All five proteins were found in spinal 
cord, and all except MDR2 were found in cerebellum. Only MRP4 was identified 
in sciatic nerve.  
 
Solute carrier. The SoLute Carrier (SLC) group includes over 300 members 
organized into 47 families44. In our study, we identified in total 112 solute carrier 
subunits/isoforms covering 33 families (supplementary table 4). 
 
Long-term potentiation and Long-term depression. Besides analysis on 
different protein families as describe above, we used Bingo 2.0 to determine 
KEGG pathways that are overrepresented in all tissue samples by a significance 
level p-value less than 0.01 (Table 5) . In total 24 pathways are overrepresented 
in the identified protein cluster, in which some could be artificially 
overrepresented because of the biased membrane fraction enrichment during 
sample preparation, e.g. ECM-receptor interaction, gap junction and tight junction, 
while some are nerve tissue specific overrepresentation, such as long-term 
potentiation 45 and long-term depression. Long-term depression is the opposite 
process of long-term potentiation, and both are considered the major cellular 
mechanisms underlying learning and memory46. In the rat IPI database v3.39, 62 
proteins/subunits are annotated to be involved in long-term potentiation and 71 in 
long-term depression. We identified 46 and 41 proteins involved in two pathways, 
respectively, in rat cerebellum (Table 6), which already coveres the majority of 











Membrane proteins are key regulators of vital processes including the passage of 
information and substances between cells and mediating activities such as 
hormone action and nerve impulses.  More than 30% of the mammalian genome 
encodes membrane proteins. These proteins are challenging to study, but pivotal 
to understand, as they represent two thirds of drug targets47. Studies on these 
proteins can potentially lead to novel and improved pharmaceutical treatments 
for broad range of diseases including disorders of the nerve system.  Mapping of 
membrane proteomes and identification of drug targets requires methods for 
tissue extraction, protein processing, and mass spectrometric analysis. Taking 
advantage of our recently developed methods for large scale identification of 
membrane proteins4, 5, 48 and our proteomic platform allowing high accuracy and 
confidential protein identification and relative quantification25 we have performed 
an in-depth comparative analysis of membrane proteomes of rat cerebellum, 
spinal cord, and sciatic nerve.  
This work provides information on in total 4,124 proteins, of which 3,528, 3,290 
and 1,649 proteins were mapped to cerebellum, spinal cord and sciatic nerve, 
respectively. From three tissues, 2,223, 2,071 and 1,009 proteins were annotated 
as membrane proteins, and 2,040, 1,891 and 856 proteins have at least one 
transmembrane domain. Around 20% of the proteins from each tissue were GO 
localized to plasma membrane. GO cellular compartment analysis, GO molecular 
function analysis and GO biological process analysis show quite similar protein 
expression patterns in the three nerve tissues.  In our study, we identified 22 
glutamate receptors, 13 GABA receptors and 3 glycine receptors. Furthermore, 
we identified 56 different subunits involved in the organization of calcium, 
potassium, sodium ion, and chloride ion channels. 
Solute carrier (SLC) and ATP-binding cassette transporter (ABC) are the major 
gene superfamilies that play essential roles in the transport of material including 





drugs across plasma and other biological membranes. This study revealed 
occurrence of 112 SLC and 27 ABC members in the nerve system.    
ABC transporter related drug resistance is a challenging obstacle in the 
treatment of cancer.  So far, substrates for 7 multidrug resistance proteins were 
identified in various cell systems41. Of these, four were identified in this study as 
integral components of nerve tissue. 
The depth of our study can also be judged by KEGG ontology and Bingo analysis 
that resulted in the identification of 24 pathways that are overrepresented. A high 
number of proteins implicated in individual pathways has been identified. These 
include protein clusters involved in long-term potentiation and depression. Thus, 
our approach can be useful for studying processes of learning and memory at the 
protein level. 
To our knowledge, this work provides the most comprehensive proteomic 
analysis of nerve tissues published to date. For the first time proteomes of 
anatomically and functionally distinct parts of the nerve system, including its 
central and peripheral components were compared.   Our approach can be taken 
as a starting point for future proteomic study of the nerve system, its 
abnormalities and illnesses.  
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Figure 1. Flow chart of membrane fraction preparation and MS analysis. 
Tissue samples were first homogenized in high salt buffer, the pellets were then 
washed twice with high pH Na2CO3 buffer and finally once with 4M Urea buffer. 
The crude membrane pellets were first dissolved overnight in 100 µl 100 mM 
CHAPS (Supernatant 1), and then dissolved again overnight in 100 µl 2% SDS 
buffer (Supernatant 2). Both supernatants were separated on size exclusion 
chromatography column into 10 fractions. The 20 fractions for each tissue 
sample were precipitated with 70% ethanol to remove detergent SDS. Pure 
membrane proteins were then redissolved in 50 mM NH4HCO3 buffer for 
overnight trypsin digestion. After desalting with C18 StageTips, peptides were 
loaded for online HPLC for mass spectrometry analysis. 
 
Figure 2. Mass Error (ppm) of the precursor ions for identified peptides 
from cerebellum.  Proteins were identified with accurate precursor ions with the 
cutoff of maximum 7ppm mass deviation for the Mascot search. The average 
mass deviation for all the peptides identified in cerebellum was -0.0688 ppm, and 
the standard deviation was 1.098 ppm. (The average and STD for spinal cord 
were -0.0061 ppm and 0.971 ppm respectively and the values for sciatic nerve 
were -0.0956ppm and 1.418ppm). The plot was performed separately for 
cerebellum only since the total identified peptides number is too large. 
 
Figure 3. Proteins identified in different tissues. Three bars of each tissue 
from left to right indicate the number of all identified proteins, membrane proteins, 
and proteins with at least one transmembrane domain.   
 
Figure 4. Subcellular localization of all annotated proteins from rat 
cerebellum (A), spinal cord (B) and sciatic nerve (C). PM, plasma membrane; 
VES, cytoplasmic membrane-bound vesicles; ER, endoplasmatic reticulum; MIT, 
mitochondria; GOL, Golgi apparatus; NUC, nucleus.    
 
Figure 5. Molecular function and biological process GO annotation of 
identified proteins from rat cerebellum. 
 
Figure 6. Pathway diagrams of long-term potentiation and long-term 
depression (retrieved from  
http://www.genome.jp/kegg/tool/search_pathway.html). Proteins in green-filled 
box indicate the presence of genes in the rat genome, and the ones with red box 
outline and red font name were identified in rat cerebellum. The genes for the 
proteins in grey boxes were not identified in the rat genome. 
  






Table 1. Summary of the identification of proteins and peptides in the nerve 
tissuesa. 
Protein category Number of identifications Cerebellum Spinal Cord Sciatic Nerve 
Non-redundant peptides 29,597 25,199 13,992 
Non-redundant proteins 3,528 3,290 1,649 
Annotated proteins 2,977 2,780 1,449 
Membrane proteins 2,223 2,071 1,009 
Proteins ≥1 TM domain 2,040 1,891 856 
    
Cellular localization    
Plasma membrane 476 474 295 
Cytoplasmic vesicle 195 198 113 
Endoplasmic reticulum 280 272 144 
Mitochondrium 497 476 270 
Golgi apparatus 227 221 105 
Nucleus 516 453 248 
 
aThe entire lists of the identified proteins and peptides are in the Supplementary 
Tables 1 and 2). 
  





Table 2. GO molecular function and biological process. 
 
 Cerebellum Spinal Cord Sciatic Nerve 
Protein 
Number 















      
Unannotated 429 12.2 392 11.9 144 8.7 
catalytic activity 1,738 49.3 1,614 49.1 825 50 
enzyme regulator activity 229 6.5 198 6 99 6 
metal ion binding 716 20.3 668 20.3 346 21 
motor activity 120 3.4 114 3.5 85 5.2 
nucleic acid binding 421 11.9 368 11.2 206 12.5 
nucleotide binding 769 21.8 703 21.4 398 24.1 
protein binding 1,723 48.8 1,605 48.8 866 52.5 
receptor activity 313 8.9 294 8.9 121 7.3 
signal transducer activity 478 13.5 444 13.5 205 12.4 
structural molecule activity 349 9.9 341 10.4 268 16.3 
transcription regulator activity 124 3.5 122 3.7 58 3.5 
translation regulator activity 36 1 31 0.9 16 1 
transporter activity 637 18.1 600 18.2 308 18.7 
       
Biological Process 
 
      
Unannotated 623 17.7 568 17.3 235 14.3 
behavior 108 3.1 102 3.1 48 2.9 
cell communication 958 27.2 861 26.2 422 25.6 
cell death 218 6.2 214 6.5 119 7.2 
cell division 33 0.9 26 0.8 19 1.2 
cell growth 25 0.7 25 0.8 13 0.8 





cell homeostasis 121 3.4 111 3.4 69 4.2 
cell motility 157 4.5 155 4.7 87 5.3 
cell organization and 
biogenesis 
925 26.2 887 27 493 29.9 
cell proliferation 162 4.6 159 4.8 93 5.6 
coagulation 27 0.8 25 0.8 27 1.6 
defense response 125 3.5 126 3.8 75 4.5 
development 719 20.4 684 20.8 396 24 
metabolism 1,900 53.9 1,785 54.3 959 58.2 
regulation of biological 
process 
878 24.9 819 24.9 433 26.3 
sensory perception 66 1.9 64 1.9 36 2.2 
transport 1,109 31.4 1,056 32.1 570 34.6 
 
  










a Protein Name 
Number of Peptides 
cerebellum Spinal Cord Sciatic Nerve 
All Uniqueb All Unique All Unique
A. Glutamate receptors  
          Ionotropic NMDA receptors       
Grin1 IPI00198625 4 Isoform A/B/C/D/F of Glutamate [NMDA] 
receptor subunit zeta-1  
11 1 5 0 0 0 
Grin1 IPI00231257 4 Isoform E/G of Glutamate [NMDA] receptor 
subunit zeta-1 
11 1 6 1 0 0 
Grin2a IPI00326054 7 Glutamate [NMDA] receptor subunit epsilon-1 6 6 3 3 0 0 
Grin2c IPI00201739 5 N-methyl-D-aspartate receptor NMDAR2C 
subunit 
4 4 0 0 0 0 
          Ionotropic AMPA receptors 
Gria1 IPI00231012 4 Isoform Flip of Glutamate receptor 1 23 2 7 1 7 2 
Gria1 IPI00324555 4 Isoform Flop of Glutamate receptor 1 22 1 8 1 6 0 
Gria2 IPI00231061 3 Isoform Flip of Glutamate receptor 2 29 1 18 1 7 1 
Gria3 IPI00195443 3 Isoform Flop of Glutamate receptor 3 22 1 13 1 4 1 
Gria3 IPI00231095 3 Isoform Flip of Glutamate receptor 3 22 2 13 2 4 2 
Gria4 IPI00231131 3 Isoform 2 of Glutamate receptor 4 23 2 9 0 6 0 
Gria4 IPI00231132 3 Isoform 3 of Glutamate receptor 4 22 1 10 0 7 0 
          Ionotropic Kainate receptors       
Grik2 IPI00324708 3 Glutamate receptor, ionotropic kainate 2 7 7 3 3 1 1 
Grik3 IPI00230977 4 Isoform GluR7A/B of Glutamate receptor, 
ionotropic kainate 3 
3 3 2 2 0 0 
          Other ionotropic receptors       
Grid1 IPI00207091 4 Glutamate receptor delta-1 subunit 8 7 5 4 1 0 





Grid2 IPI00206854 3 Glutamate receptor delta-2 subunit 40 39 18 17 23 22 
Grid2ip IPI00870890 0 glutamate receptor, ionotropic, delta 2 (Grid2) 
interacting protein 1 
22 22 1 1 7 7 
          Metabotropic receptors       
Grm1 IPI00210260 6 Isoform 1A/B/C of Metabotropic glutamate 
receptor 1 
25 25 5 5 7 7 
Grm2 IPI00212618 6 Metabotropic glutamate receptor 2 12 9 3 2 4 3 
Grm3 IPI00769125 9 Metabotropic glutamate receptor 3 8 6 6 5 2 1 
Grm4 IPI00327692 7 Metabotropic glutamate receptor 4 12 11 2 2 1 1 
Grm5 IPI00212621 6 Isoform 1/2 of Metabotropic glutamate 
receptor 5 
0 0 2 2 0 0 
Grm7 IPI00198587 8 Metabotropic glutamate receptor 7 2 2 2 2 0 0 
        
B. GABA receptors       
          GABA A receptors       
Gabra1 IPI00192642 2 Gamma-aminobutyric acid receptor subunit 
alpha-1 
13 6 9 4 4 2 
Gabra2 IPI00679252 2 Gamma-aminobutyric acid receptor subunit 
alpha-2 
7 2 6 2 2 0 
Gabra3 IPI00197343 2 Gamma-aminobutyric acid receptor subunit 
alpha-3 
4 0 6 3 2 0 
Gabra5 IPI00325359 3 Gamma-aminobutyric acid receptor subunit 
alpha-5 
4 0 4 1 1 0 
Gabra6 IPI00206049 4 Gamma-aminobutyric acid receptor subunit 
alpha-6 
12 12 1 1 7 7 
Gabrb1 IPI00209268 3 Gamma-aminobutyric acid receptor subunit 
beta-1 
8 2 7 2 4 0 
Gabrb2 IPI00209269 2 Gamma-aminobutyric acid receptor subunit 
beta-2 
16 8 5 0 5 1 
Gabrb3 IPI00327083 2 Gamma-aminobutyric acid receptor subunit 
beta-3 
11 5 7 3 5 2 
Gabrd IPI00192644 3 Gamma-aminobutyric acid receptor subunit 8 8 0 0 3 3 






Gabrg1 IPI00211960 2 Gamma-aminobutyric acid receptor subunit 
gamma-1 
3 2 3 2 1 0 
Gabrg2 IPI00192646 2 Gamma-aminobutyric acid receptor subunit 
gamma-2 
4 3 3 2 2 1 
          GABA B receptors       
Gabbr1 IPI00208182 7 Gamma-aminobutyric acid type B receptor 
subunit 1 
9 9 6 6 3 3 
Gabbr2 IPI00331966 7 Gamma-aminobutyric acid type B receptor 
subunit 2 
13 13 4 4 2 2 
          
C. Glycine receptors 
Glra1 IPI00206855 4 Isoform a/b of Glycine receptor subunit alpha-
1 
0 0 7 6 0 0 
Glra3 IPI00392219 4 Glycine receptor alpha 3 1 1 2 1 0 0 
Glrb IPI00202491 5 Glycine receptor subunit beta 1 1 10 10 0 0 
 
aTM: number of predicted transmembrane domain by TMAP algorithm; b unique peptide is the peptide with a sequence specific to the 
protein but not shared with other proteins  










a Protein Name 
Number of Peptides 
Cerebellum Spinal Cord Sciatic 
Nerve 
All Uniqueb All Unique All Unique
Voltage-gated Ca2+ channels       
Cacna1a IPI00197594 4 Class A calcium channel variant riA-I 
(Fragment) 
6 1 0 0 1 0 
Cacna1a IPI00211870 23 calcium channel, voltage-dependent, P/Q 
type, alpha 1A subunit 
19 13 3 2 3 1 
Cacna1b IPI00200639 24 Voltage-dependent N-type calcium 
channel subunit alpha-1B 
4 4 0 0 0 0 
Cacna1e IPI00198751 23 Voltage-dependent R-type calcium 
channel subunit alpha-1E 
7 6 2 1 1 0 
Cacna1g IPI00196758 22 Voltage-dependent calcium channel T 
type alpha 1G subunit 
6 6 0 0 0 0 
Cacna2d1 IPI00391769 3 Voltage-dependent calcium channel 
subunit alpha-2/delta-1 
35 34 30 30 3 3 
Cacna2d2 IPI00191089 3 Voltage-dependent calcium channel 
subunit alpha-2/delta-2 
25 24 17 17 4 4 
Cacna2d3 IPI00191088 1 Voltage-dependent calcium channel 
subunit alpha-2/delta-3 
10 10 9 9 0 0 
Cacnb2 IPI00421663 0 Voltage-dependent L-type calcium 
channel subunit beta-2 
4 1 2 0 1 0 
Cacnb3 IPI00211876 1 Voltage-dependent L-type calcium 
channel subunit beta-3 






0 Voltage-dependent L-type calcium 
channel subunit beta-1/beta-4 
8 5 5 3 1 0 
Cacng2 IPI00201313 3 Voltage-dependent calcium channel 
gamma-2 subunit 
8 8 7 7 2 2 
Cacng5 IPI00207430 3 Voltage-dependent calcium channel 
gamma-5 subunit 
2 2 0 0 0 0 
Cacng8 IPI00207426 4 Voltage-dependent calcium channel 3 3 4 4 2 2 






          
Voltage-gated K+ channels (Kv)       
Kcna1 IPI00190644 7 Potassium voltage-gated channel 
subfamily A member 1 
13 7 12 6 8 4 
Kcna2 IPI00208365 7 Potassium voltage-gated channel 
subfamily A member 2 
8 2 8 2 6 2 
Kcna3 IPI00208359 7 Potassium voltage-gated channel 
subfamily A member 3 
7 1 7 1 4 0 
Kcna4 IPI00208362 7 Potassium voltage-gated channel 
subfamily A member 4 
2 1 4 3 1 0 
Kcna6 IPI00190053 7 Potassium voltage-gated channel 
subfamily A member 6 
4 3 5 4 1 0 
Kcnab2 IPI00211012 0 Voltage-gated potassium channel subunit 
beta-2 
7 2 10 2 3 0 
Kcnab2 IPI00780996 0 47 kDa protein 6 1 9 1 3 0 
Kcnd2 IPI00394218 6 Potassium voltage-gated channel 
subfamily D member 2 
10 9 4 3 1 0 
Kcnd3 IPI00389372 5 Potassium voltage-gated channel 
subfamily D member 3 





4 Potassium voltage-gated channel 
subfamily H member 1 or 5 
3 3 0 0 0 0 
Kcnq2 IPI00214278 6 Potassium voltage-gated channel 
subfamily KQT member 2 
2 2 2 2 0 0 
          
Voltage-gated Na+ channels       
Scn1a IPI00198841 23 Sodium channel protein type 1 subunit 
alpha 
23 7 12 5 4 0 
Scn2a1 IPI00400699 23 Sodium channel protein type 2 subunit 
alpha 
46 1 9 0 8 0 
Scn4a or 
Scn5a 
IPI00339065 26 Sodium channel protein type 4/5 subunit 
alpha 
8 1 4 0 3 0 





Scn7a IPI00326646 24 Sodium channel;Glial voltage-gated 
sodium channel 
2 2 5 5 8 8 
Scn8a IPI00213193 25 Voltage-gated sodium channel variant 
rPN4a 
11 2 6 2 1 0 
Scn1b IPI00204294 1 Sodium channel subunit beta-1 8 8 5 5 0 0 
Scn2b IPI00189882 1 Sodium channel subunit beta-2 7 7 3 3 1 1 
Scn3b IPI00201894 1 Sodium channel subunit beta-3 0 0 2 2 0 0 
Scn4b IPI00369414 1 Sodium channel subunit beta-4 5 5 5 5 1 1 
          
Voltage-gated chloride channels (CLC)       
Clcn2 IPI00199560 11 Chloride channel protein 2 6 6 6 6 0 0 
Clcn3 IPI00476274 10 Chloride channel protein 3 7 1 4 1 0 0 
Clcn3 IPI00566593 10 Chloride channel protein 3 long form 
(Fragment) 
6 0 4 1 0 0 
Clcn4-2 IPI00205423 11 chloride channel 4 6 5 5 4 0 0 
Clcn5 IPI00326242 11 Chloride channel protein 5 2 1 4 3 0 0 
Clcn6 IPI00369827 10 chloride channel 6 11 11 10 10 2 2 
Clcn7 IPI00205428 10 Chloride channel protein 7 1 1 2 2 0 0 
          
Chloride intracellular channels       
Clic1 IPI00421995 1 Chloride intracellular channel 1 1 1 2 2 4 4 
Clic4 IPI00208249 1 Chloride intracellular channel protein 4 2 2 3 3 1 1 
Clcc1 IPI00203434 3 Chloride channel CLIC-like protein 1  1 1 2 2 0 0 
 
aTM: number of predicted transmembrane domain by TMAP algorithm; b unique peptide is the peptide with a sequence specific to the 
protein but not shared with other proteins 










a Protein Name 
Number of Peptides 
Cerebellum Spinal Cord Sciatic 
Nerve 
All Uniqueb All Unique All Unique
 
Multidrup resistance proteins 
      
Abcb1a/b IPI00470287 10 Multidrug resistance protein 1a/b 29 1 22 1 4 0 
Abcb4 IPI00198519 10 Multidrug resistance protein 2 6 0 5 1 0 0 
Abcc1 IPI00331756 17 Multidrug resistance-associated protein 1 4 4 1 1 0 0 
Abcc4 IPI00421457 11 ATP-binding cassette protein C4 6 3 7 3 1 1 
Abcg2 IPI00327093 5 ATP-binding cassette sub-family G member 
2 
7 7 6 6 0 0 
          
Other ABC transporters       
Abca1 IPI00287199 11 ATP-binding cassette 1 4 4 2 2 0 0 
Abca2 IPI00192286 14 ATP-binding cassette sub-family A member 
2 
14 14 10 10 0 0 
Abca3 IPI00368700 12  ATP-binding cassette sub-family A member 
3 
4 4 1 1 0 0 
Abca5 IPI00190668 12 ATP-binding cassette sub-family A member 
5 
7 7 4 4 1 1 
Abca7 IPI00382157 12 ATP-binding cassette sub-family A member 
7 
3 3 1 1 0 0 
Abca8a IPI00361512 13 ATP-binding cassette, sub-family A (ABC1), 
member 8a 
1 1 1 1 2 2 
Abca9 or 
Abca8b 
IPI00765350 13 ATP-binding cassette transporter sub-family 
A member 9/8b 
2 1 1 0 2 1 
Abcb6 IPI00199586 10 Mitochondrial ATP-binding cassette sub-
family B member 6 
3 3 3 3 0 0 
Abcb7 IPI00421940 6 ATP-binding cassette sub-family B member 
7, mitochondrial 
20 20 16 16 5 5 





Abcb8 IPI00200542 5 ABC transporter 8 13 10 10 7 2 1 
Abcb8 IPI00781425 0 14 kDa protein 4 1 4 1 2 1 
Abcb9 IPI00214174 9 ATP-binding cassette sub-family B member 
9 
3 3 4 4 1 1 
Abcb10 IPI00189064 5 ATP-binding cassette, sub-family B 
(MDR/TAP), member 10 
10 10 11 11 2 2 
Abcc8 IPI00204427 14 ATP-binding cassette transporter sub-family 
C member 8 
6 6 1 1 0 0 
Abcd1 IPI00559296 6 ATP-binding cassette, sub-family D (ALD), 
member 1 
1 1 4 4 0 0 
Abcd2 IPI00213550 6 ATP-binding cassette sub-family D member 
2 
6 6 8 8 0 0 
Abcd3 IPI00231860 5 ATP-binding cassette sub-family D member 
3 
9 9 11 11 5 5 
Abce1 IPI00193816 0 ATP-binding cassette, sub-family E (OABP), 
member 1 
0 0 2 2 0 0 
Abcf2 IPI00213162 0 Abcf2_predicted protein 5 5 6 6 0 0 
Abcf3 IPI00370458 0 ATP-binding cassette sub-family F member 
3 
1 1 2 2 0 0 
Abcg1 IPI00189036 6 ABC transporter, white homologue 4 4 2 2 0 0 
Abcg3 IPI00470299 5 ATP-binding cassette, sub-family G 
(WHITE), member 3 
3 1 4 1 1 1 
 
aTM: number of predicted transmembrane domain by TMAP algorithm; b unique peptide is the peptide with a sequence specific to the 
protein but not shared with other proteins   





Table 6. KEGG pathways (http://www.genome.jp/kegg/) overrepresented in our identified dataset with a p-value 














5030 Amyotrophic lateral sclerosis 
(ALS) 
30 14 5.52E-04 13 1.97E-03 11 1.07E-03
4730 Long-term depression 71 41 6.06E-06 38 7.56E-05 29 1.65E-04
4720 Long-term potentiation 62 46 8.43E-12 46 3.39E-12 30 2.14E-06
4540 Gap junction 89 48 1.32E-05 47 1.72E-05 32 1.15E-03
4530 Tight junction 125 61 5.65E-05 62 1.17E-05 43 5.20E-04
4512 ECM-receptor interaction 68 36 2.62E-04 36 1.57E-04 31 7.02E-06
4510 Focal adhesion 176 77 5.89E-04 74 1.42E-03 60 5.65E-05
4130 SNARE interactions in 
vesicular transport 
36 30 2.64E-10 30 1.40E-10 21 1.58E-06
3050 Proteasome 25 19 7.85E-06 19 5.37E-06 13 7.60E-04
3010 Ribosome 68 44 2.57E-08 45 2.73E-09 41 3.12E-12
1430 Cell Communication 118 55 5.78E-04 51 3.90E-03 57 5.14E-11
930 Caprolactam degradation 8 8 1.11E-04 8 9.23E-05 6 1.85E-03
720 Reductive carboxylate cycle 
(CO2 fixation) 
8 8 1.11E-04 8 9.23E-05 7 1.38E-04
650 Butanoate metabolism 31 24 2.54E-07 22 6.29E-06 14 2.74E-03
640 Propanoate metabolism 23 19 8.01E-07 19 5.38E-07 13 2.58E-04
620 Pyruvate metabolism 28 21 3.65E-06 21 2.41E-06 18 1.22E-06
480 Glutathione metabolism 29 20 4.80E-05 20 3.30E-05 14 1.24E-03
280 Valine, leucine and isoleucine 
degradation 
34 29 1.72E-10 28 1.02E-09 17 2.19E-04
190 Oxidative phosphorylation 102 73 1.25E-16 73 3.01E-17 67 2.32E-22
100 Biosynthesis of steroids 21 15 2.43E-04 17 3.81E-06 11 1.81E-03
71 Fatty acid metabolism 40 29 1.63E-07 29 9.27E-08 18 7.39E-04
62 Fatty acid elongation in 10 8 2.56E-03 8 2.17E-03 7 1.37E-03






20 Citrate cycle (TCA cycle) 21 19 3.89E-08 19 2.56E-08 16 1.29E-07
10 Glycolysis / Gluconeogenesis 44 23 4.15E-03 24 1.13E-03 22 2.61E-05
 
*The p-value was calculated by the hypergeometric test for identified rat proteins w.r.t the complete rat proteome. 
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7 Summary and perspectives 
The work presented in this thesis describe my effort to develop optimal MS-based 
proteomics techniques for high sequence mapping of relative pure protein samples as 
well as membrane protein identification from tissue samples. 
Dynamic range and sensitivity are two critical issues related to MS-based proteomics. 
Real biological samples, even the peptide digested from the same protein, can display a 
dynamic range of several thousand to more than 1010.  Fractionation starting from 
separating high intensity proteins from the low proteins at the beginning of sample 
preparation to the segmentation of high intensity m/z peak to low intensity ones at the 
final data acquisition step, increases the dynamic range of MS identifications. In the 
peptide mapping approach, we introduce the concept of “composite spectra”, which are 
spectra composed of a high number of segmented SIM scans. High abundant mass ranges 
and low abundant ranges are acquired separately. These composite spectra allow very 
high sensitivity, accuracy and dynamic range due to optimized fill times for each mass 
segment. The dynamic range of the approaches could be further increased by coupling 
off-line HPLC separation of the peptides before spray. By applying this approach to 
histone H1 samples from human breast cancer, on average around 80% sequence 
coverage was obtained for the K/R rich histone H1 variants, H1.0, H1.2-4, and H1.5. 
Another advantage of the peptide mapping approach is that it is possible to quantify the 
occupancy for different modifications in a single spectrum, since all peptides come out 
simultaneously at a stable spray rate. 
Detergent is an indispensible chemical to dissolve membrane proteins, however, even a 
small amount of detergent is incompatible with MS acquisition of the peptides. Normally 
MS-based proteomics protocols starting with detergent dissolving removes the detergent 
in a gel based method. In our project, we were able to demonstrate that detergent can be 
completely removed by solvent exchange in a desalting column. Compared to the gel 
based approach, it is fast and more importantly, results in much higher recovery of high 
mass proteins, which may not enter the gel matrix. With the help of advanced LTQ-
Orbitrap techniques, we are able to identify nearly 1000 membrane proteins from a single 





MS analysis. To increase the identification number, we incorporated gel filtration 
chromatography, a method compatible with detergent, which increased the number to 
3000 for one sample. Mining different family of membrane proteins, e.g. receptors, ion 
channels, our method demonstrates the possibility to identify most of them. 
Although the techniques developed here are clearly powerful, they can still be further 
developed. For example, in the writing of the histone H1 methylation manuscript, we 
found a disadvantage of using methanol as the spray buffer: Glutamic acid shows strong 
artifactual methylation in buffers containing methanol. This necessitated discarding many 
potential methylation sites because they were indistinguishable from artifactual 
methylation. This includes a very interesting discovery of a possible phospho-switch in 
H1.4 at K17/T18. Due to the limitation of sample and time, we did not repeat the 
experiment with other organic solvent, e.g. ethanol or acetonitrile, but this would be 
interesting for further studies. 
Techniques for sample preparation develop very fast, especially in our laboratory. Prof. 
Jacek R. Wiśniewski has recently developed a protocol call “FASP”, which results in 
very clean protein sample. Combine with OFFGEL peptide separation, it is possible to 
identify more than 6000 proteins in one experiment and the number of identified 
membrane protein is more than 3000. This raises the question, when and where is 
necessary to purify membrane proteins. If it is only for the identification level, with so far 
developed sample preparation techniques and MS instrument, it might seem of less 
interest to separate membrane proteins from the soluble proteins. Although 
subfractionation increases dynamic range, extra procedure causes more sample loss, in 
particular the low abundant membrane proteins. However, when the cellular localization 
of protein is of interest, it is still worthwhile to perform membrane protein enrichment. 
The algorithmic and software development of label free quantitation in our group will 
now make comparative proteomics much more valuable. However, for robust 
quantitation, several repeat runs are necessary.  
In conclusion, the chip implementation of nanoelectrospray method provides an 
alternative way to HPLC-ESI-MS or MALDI-MS for individual protein sequence 





mapping and PTM characterization. It is a method with high sensitivity and high dynamic 
range. From the application to linker histone H1, we can see that the method has the 
further advantage of identifying tryptic peptides of a length of five to six amino acids, 
which normally are missed in HPLC-MS based analysis.  This thesis also reports, for the 
first time, large-scale membrane proteomics for nerve tissue, especially the peripheral 
nerve tissue. Most of the known receptors and ion channel proteins were identified. Our 
detergent-based gel-free protocol enable identification of nearly 1000 proteins within a 
single MS run, and the total time from tissue homogenization to start trypsin digestion is 
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